INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY
ENVIRONMENTAL HEALTH CRITERIA 87
ALLETHRINS
- Allethrin
- d-Allethrin
- Bioallethrin
- S-Bioallethrin
This report contains the collective views of an international group of
experts and does not necessarily represent the decisions or the stated
policy of the United Nations Environment Programme, the International
Labour Organisation, or the World Health Organization.
Published under the joint sponsorship of
the United Nations Environment Programme,
the International Labour Organisation,
and the World Health Organization
World Health Orgnization
Geneva, 1989
The International Programme on Chemical Safety (IPCS) is a
joint venture of the United Nations Environment Programme, the
International Labour Organisation, and the World Health
Organization. The main objective of the IPCS is to carry out and
disseminate evaluations of the effects of chemicals on human health
and the quality of the environment. Supporting activities include
the development of epidemiological, experimental laboratory, and
risk-assessment methods that could produce internationally
comparable results, and the development of manpower in the field of
toxicology. Other activities carried out by the IPCS include the
development of know-how for coping with chemical accidents,
coordination of laboratory testing and epidemiological studies, and
promotion of research on the mechanisms of the biological action of
chemicals.
ISBN 92 4 154287 X
The World Health Organization welcomes requests for permission
to reproduce or translate its publications, in part or in full.
Applications and enquiries should be addressed to the Office of
Publications, World Health Organization, Geneva, Switzerland, which
will be glad to provide the latest information on any changes made
to the text, plans for new editions, and reprints and translations
already available.
(c) World Health Organization 1989
Publications of the World Health Organization enjoy copyright
protection in accordance with the provisions of Protocol 2 of the
Universal Copyright Convention. All rights reserved.
The designations employed and the presentation of the material
in this publication do not imply the expression of any opinion
whatsoever on the part of the Secretariat of the World Health
Organization concerning the legal status of any country, territory,
city or area or of its authorities, or concerning the delimitation
of its frontiers or boundaries.
The mention of specific companies or of certain manufacturers'
products does not imply that they are endorsed or recommended by the
World Health Organization in preference to others of a similar
nature that are not mentioned. Errors and omissions excepted, the
names of proprietary products are distinguished by initial capital
letters.
CONTENTS
ENVIRONMENTAL HEALTH CRITERIA FOR ALLETHRINS
INTRODUCTION
1. SUMMARY
1.1. Identity, physical and chemical properties, analytical
methods
1.2. Production and uses
1.3. Residues in food
1.4. Environmental fate
1.5. Kinetics and metabolism
1.6. Effects on experimental animals and in vitro test systems
1.7. Effects on organisms in the environment
2. IDENTITY, PHYSICAL AND CHEMICAL PROPERTIES, ANALYTICAL METHODS
2.1. Identity
2.2. Physical and chemical properties
2.3. Analytical methods
3. SOURCES IN THE ENVIRONMENT, ENVIRONMENTAL TRANSPORT,
DISTRIBUTION AND TRANSFORMATION, ENVIRONMENTAL LEVELS AND HUMAN
EXPOSURE
3.1. Industrial production
3.2. Use patterns
3.3. Environmental transport, distribution, and transformation
3.4. Environmental levels and human exposure
3.4.1. Residues in food
4. KINETICS AND METABOLISM
4.1. Metabolism in mammals
4.2. Enzymatic systems for biotransformation
5. EFFECTS ON ORGANISMS IN THE ENVIRONMENT
5.1. Aquatic organisms
5.2. Terrestrial organisms
6. EFFECTS ON EXPERIMENTAL ANIMALS AND IN VITRO TEST SYSTEMS
6.1. Acute toxicity
6.2. Short-term studies
6.2.1. Allethrin
6.2.2. d-Allethrin
6.2.3. Bioallethrin
6.2.4. S-Bioallethrin
6.3. Primary irritation
6.3.1. Eye irritation
6.3.2. Skin irritation
6.4. Sensitization
6.5. Long-term studies and carcinogenicity
6.6. Mutagenicity and related end-points
6.7. Reproductive effects, embryotoxicity, and teratogenicity
6.8. Potentiation
6.9. Mechanism of toxicity - mode of action
7. EFFECTS ON MAN
8. EVALUATION OF HUMAN HEALTH RISKS AND EFFECTS ON THE ENVIRONMENT
8.1. Evaluation of human health risks
8.2. Evaluation of effects on the environment
9. CONCLUSIONS
10. RECOMMENDATIONS
11. PREVIOUS EVALUATIONS BY INTERNATIONAL BODIES
REFERENCES
APPENDIX
WHO TASK GROUP ON ENVIRONMENTAL HEALTH CRITERIA FOR ALLETHRINS AND
RESMETHRINS
Members
Dr L.A. Albert-Palacios, National Institute of Biological Resources
Research, Xalapa, Veracruz, Mexicoa
Dr V. Benes, Institute of Hygiene and Epidemiology, Prague,
Czechoslovakia
Dr A.H. El-Sabae, Faculty of Agriculture, Alexandria University,
Alexandria, Egypt
Dr Y. Hayashi, National Institute of Hygienic Sciences, Tokyo,
Japan
Dr S. Johnson, US Environmental Protection Agency, Hazard
Evaluation Division, Washington DC, USA
Dr S.K. Kashyap, National Institute of Occupational Health,
Ahmedabad, India (Vice-Chairman)
Dr J.H. Koeman, Agricultural University, Wageningen, Netherlandsa
Dr Yu. I. Kundiev, Research Institute of Labour, Hygiene and
Occupational Diseases, Kiev, USSR (Chairman)
Dr J.P. Leahey, ICI Agrochemicals Division, Jealotts Hill Research
Station, Bracknell, Berkshire, United Kingdom (Rapporteur)
Dr M. Matsuo, Sumitomo Chemical Co. Ltd, Takarazuka Research
Center, Takarazuka, Hyogo, Japan
Dr G.U. Oleru, College of Medicine, University of Lagos, Lagos,
Nigeria
Observers
Mr J.-M. Pochon, International Group of National Associations of
Agrochemical Manufacturers, Brussels, Belgium
Dr L.M. Sasynovitch, Research Institute of Hygiene and Toxicology
of Pesticides, Polymers and Plastics, Kiev, USSR
Secretariat
Dr Z.P. Grigorevskaja, Centre for International Projects, Moscow,
USSR
___________________________________________________________________
a Invited but unable to attend.
Secretariat (contd.)
Dr K.W. Jager, International Programme on Chemical Safety, World
Health Organization, Geneva, Switzerland (Secretary)
Dr J. Sekizawa, National Institute of Hygienic Sciences, Tokyo,
Japan (Rapporteur)
NOTE TO READERS OF THE CRITERIA DOCUMENTS
Every effort has been made to present information in the
criteria documents as accurately as possible without unduly
delaying their publication. In the interest of all users of the
environmental health criteria documents, readers are kindly
requested to communicate any errors that may have occurred to the
Manager of the International Programme on Chemical Safety, World
Health Organization, Geneva, Switzerland, in order that they may be
included in corrigenda, which will appear in subsequent volumes.
* * *
A detailed data profile and a legal file can be obtained from
the International Register of Potentially Toxic Chemicals, Palais
des Nations, 1211 Geneva 10, Switzerland (Telephone no. 988400 -
985850).
ENVIRONMENTAL HEALTH CRITERIA FOR ALLLETHRINS
A WHO Task Group on Environmental Health Criteria for
Allethrins and Resmethrins met in Moscow from 16 - 20 November
1987. The meeting was convened with the financial assistance of
the United Nations Environment Programme (UNEP) and was hosted by
the Centre for International Projects of the USSR State Committee
on Science and Technology. On behalf of the USSR Commission for
UNEP (UNEPCOM), Dr M. I. Gounar opened the Meeting and welcomed the
participants. Dr K.W. Jager welcomed the participants on behalf of
the Heads of the three IPCS cooperating organizations (UNEP/ILO/WHO).
The Group reviewed and revised the draft Environmental Health
Criteria and Health and Safety Guides and made an evaluation of the
risks for human health and the environment from exposure to
allethrins and resmethrins.
The first drafts of the documents were prepared by Dr J.
Miyamoto and Dr M. Matsuo of Sumitomo Chemical Co. Ltd, with the
assistance of the staff of the National Institute of Hygienic
Sciences, Tokyo, Japan. Dr I. Yamamoto of the Tokyo University of
Agriculture and Dr M. Eto of Kyushu University, Japan, assisted in
the finalization of the draft.
The second draft was prepared by Dr J. Sekizawa of the National
Institute of Hygienic Sciences, Tokyo, incorporating comments
received following the circulation of the first draft to the IPCS
contact points for Environmental Health Criteria documents.
The help of the Sumitomo Chemical Company Ltd, Japan and
Roussel Uclaf, France in making their toxicological proprietary
information on allethrins and resmethrins available to the IPCS and
the Task Group is gratefully acknowledged. This enabled the Task
Group to make their evaluation on a more complete data base.
The efforts of all who helped in the preparation and
finalization of the documents are gratefully acknowledged.
* * *
Partial financial support for the publication of this criteria
document was kindly provided by the United States Department of
Health and Human Services, through a contract from the National
Institute of Environmental Health Sciences, Research Triangle Park,
North Carolina, USA - a WHO collaborating Centre for Environmental
Health Effects. The United Nations Environment Programme (UNEP)
generously supported the costs of printing.
* * *
NOTE: The proprietary information contained in this document
cannot replace documentation for registration purposes, because the
latter has to be closely linked to the source, the manufacturing
route, and the purity/impurities of the substance to be registered.
The data should be used in accordance with paragraphs 82 - 84 and
recommendations paragraph 90 of the 2nd FAO Government Consultation
(1982).
INTRODUCTION
SYNTHETIC PYRETHROIDS-A PROFILE
1. During investigations to modify the chemical structures of
natural pyrethrins, a certain number of synthetic pyrethroids
were produced with improved physical and chemical properties
and greater biological activity. Several of the earlier
synthetic pyrethroids were successfully commercialized,
mainly for the control of household insects. Other more
recent pyrethroids have been introduced as agricultural
insecticides because of their excellent activity against a
wide range of insect pests and their non-persistence in the
environment.
2. The pyrethroids constitute another group of insecticides in
addition to organochlorine, organophosphorus, carbamate, and
other compounds. Pyrethroids commercially available to date
include allethrin, resmethrin, d-phenothrin, and tetramethrin
(for insects of public health importance), and cypermethrin,
deltamethrin, fenvalerate, and permethrin (mainly for
agricultural insects). Other pyrethroids are also available
including furamethrin, kadethrin, and tellallethrin (usually
for household insects), fenpropathrin, tralocythrin and
tralomethrin, cyhalothrin, lambda-cyhalothrin, tefluthrin,
cyfluthrin, flucythrinate, fluvalinate, and biphenate (for
agricultural insects).
3. Toxicological evaluations of several synthetic pyrethroids
have been performed by the FAO/WHO Joint Meeting on Pesticide
Residues (JMPR). The acceptable daily intake (ADI) or
temporary ADI has been estimated by the JMPR for
cypermethrin, deltamethrin, fenvalerate, permethrin,
phenothrin, cyfluthrin, cyhalothrin, and flucythrinate.
4. Chemically, synthetic pyrethroids are esters of specific
acids (e.g., chrysanthemic acid, halo-substituted
chrysanthemic acid, 2-(4-chlorophenyl)-3-methylbutyric acid)
and alcohols (e.g., allethrolone, 3-phenoxybenzyl alcohol).
For certain pyrethroids, the asymmetric centre(s) exist in
the acid and/or alcohol moiety, and the commercial products
sometimes consist of a mixture of both optical (1R/1S or d/1)
and geometric ( cis/trans)-isomers. However, most of the
insecticidal activity of such products may reside in only one
or two isomers. Some of the products (e.g., d-phenothrin,
deltamethrin) consist only of such active isomer(s).
5. Synthetic pyrethroids are neuropoisons acting on the axons
in the peripheral and central nervous systems by interacting
with sodium channels in mammals and/or insects. A single
dose produces toxic signs in mammals, such as tremors,
hyperexcitability, salivation, choreoathetosis, and
paralysis. The signs disappear fairly rapidly, and the
animals recover, generally within a week. At near-lethal
dose levels, synthetic pyrethroids cause transient changes in
the nervous system, such as axonal swelling and/or breaks and
myelin degeneration in sciatic nerves. They are not
considered to cause delayed neurotoxicity of the kind induced
by some organophosphorus compounds. The mechanism of
toxicity of synthetic pyrethroids and their classification
into two types are discussed in the Appendix.
6. Some pyrethroids (e.g., deltamethrin, fenvalerate,
flucythrinate, and cypermethrin) may cause a transient
itching and/or burning sensation in exposed human skin.
7. Synthetic pyrethroids are generally metabolized in mammals
through ester hydrolysis, oxidation, and conjugation, and
there is no tendency to accumulate in tissues. In the
environment, synthetic pyrethroids are fairly rapidly
degraded in soil and in plants. Ester hydrolysis and
oxidation at various sites on the molecule are the major
degradation processes. The pyrethroids are strongly adsorbed
on soil and sediments, and hardly eluted with water. There
is little tendency for bioaccumulation in organisms.
8. Because of low application rates and rapid degradation in the
environment, residues in food are generally low.
9. Synthetic pyrethroids have been shown to be toxic for fish,
aquatic arthropods, and honey-bees in laboratory tests. But,
in practical usage, no serious adverse effects have been
noticed, because of the low rates of application and lack of
persistence in the environment. The toxicity of synthetic
pyrethroids in birds and domestic animals is low.
10. In addition to the evaluation documents of FAO/WHO, there
are several reviews and books on the chemistry, metabolism,
mammalian toxicity, environmental effects, etc. of synthetic
pyrethroids, including those by Elliot (1977), Miyamoto
(1981), Miyamoto & Kearney (1983), and Leahey (1985).
1. SUMMARY
1.1 Identity, Physical and Chemical Properties, Analytical
Methods
Allethrin was the first synthetic pyrethroid to be synthesized
(in 1949) and was marketed in 1952. Chemically, it is an ester
of chrysanthemic acid (CA), 2,2-dimethyl-3-(2,2-dimethylvinyl)
cyclopropanecarboxylic acid with allethrolone and it
is a racemic mixture of 8 stereoisomers: [1R, trans;1R]-,
[1R, trans;1S]-, [1R, cis;1R]-, [1R, cis;1S]-, [1S, trans;1R]-,
[1S, trans;1S]-, [1S, cis;1R]-, and [1S, cis;1S]-isomer. The ratio
of the above isomers in the technical material is approximately
1:1:1:1:1:1:1:1. Among the isomers, the [1R, trans;1S]-isomer is
the most biologically active followed by the [1R, cis;1S]-isomer.
d-Allethrin consists of [1R, trans;1R]-, [1R, trans;1S]-,
[1R, cis;1R]-, and [1R, cis;1S]-isomers in an approximate ratio of
4:4:1:1. Bioallethrin and esbiothrin consist of [1R, trans;1R]-
and [1R, trans;1S]-isomers. The isomeric composition of the former
is approximately 1:1 and that of the latter, 1:3. S-Bioallethrin
is the [1R, trans;1S]-isomer.
Allethrin is a clear, pale-yellow oil with a boiling point of
140 °C at a pressure of 0.1 mmHg; it is 75 - 95% pure. The
specific gravity is 1.005 at 25 °C. Allethrin is practically
insoluble in water, but soluble in organic solvents, such as
methanol, hexane, and xylene. It is unstable in light, air, and
under alkaline conditions. It is decomposed by rapid pyrolysis at
over 400 °C, but vaporizes without decomposing, when heated at
150 °C. It is fairly volatile.
d-Allethrin is an oily liquid (specific gravity of 1.005 -
1.015 at 20 °C).
Bioallethrin is an amber-coloured, viscous liquid.
Esbiothrin is a yellow, viscous liquid.
S-Bioallethrin is a yellow liquid.
Allethrin residues and levels in environmental samples are
determined by dual-wavelength densitometry (370 or 230 nm), or by
derivatisation and colorimetric measurement at levels as low as
0.1 mg/litre. A gas chromatograph with flame ionization detector
is used for analysis of the technical product.
1.2 Production and Uses
It is estimated that several hundred tonnes of allethrin,
d-allethrin, bioallethrin, esbiothrin, and S-Bioallethrin are
manufactured and used yearly throughout the world, mainly for the
control of household insects. Formulations include concentrates,
aerosol sprays, smoke coils, electric mats, and emulsifiable with
or without synergists or other insecticides.
1.3 Residues in Food
No information is available on the levels of allethrin residues
in treated crops. Allethrin was not detected in the milk of dairy
cows or in the meat of a female goat, which had been sprayed daily
for 3 and 5 weeks, respectively (limit of detection of method used
- 0.1 mg/kg).
1.4 Environmental Fate
The photodegradation rate was measured of a thin film of
allethrin on glass under a sun lamp. Approximately 8 h of exposure
were needed for 90% degradation. S-Bioallethrin was rapidly
decomposed, when similarly exposed to sunlight. The major
photoreactions were ester cleavage, di-pi-methane rearrangement,
oxidation at the isobutenyl methyl group, epoxidation at the
isobutenyl double bond, and cis/trans-isomerization. The major
degradation products formed were CA, the 3-(2-hydroxymethyl) or the
3-(1-epoxy) derivative of allethrin, and cyclopropylrethronyl
chrysanthemate. Sunlight photolysis of allethrin in solution
yielded similar products. Allethrin was decomposed by rapid
pyrolysis at over 400 °C. When kept at 150 °C for 9 h in an
aluminum foil vessel in air, it vaporized (28 - 35%), polymerized
(24 - 45%), and decomposed (18 - 40%). CA, allethrolone, pyrocin,
and cis-dihydrochrysanthemo-delta-lactone were the degradation
products formed.
1.5 Kinetics and metabolism
When 14C-acid- or 3H-alcohol-labelled allethrin was
administered orally to rats at a rate of 1 - 5 mg/kg body weight,
the radiocarbon and tritium were eliminated in the urine (30% and
20.7%, respectively) and faeces (29% and 27%, respectively) within
48 h. The major metabolic reactions were ester hydrolysis,
oxidation at the trans-methyl of the isobutenyl group, gem-dimethyl
of the cyclopropane ring, and the methylene of the allyl group, and
2,3-diol formation at the allylic group. The major urinary
metabolites were chrysanthemum dicarboxylic acid, allethrolone, and
some oxidized forms of allethrin.
1.6 Effects on Experimental Animals and In Vitro Test Systems
The acute oral toxicities of all the allethrins are weak to
moderate with LD50 values ranging from 210 mg/kg body weight
(mouse) to 4290 mg/kg (rabbit). On the basis of limited data, the
dermal toxicity appears to be very low (LD50 > 2000 for the
rabbit). The inhalation toxicity values (LC50 values) for the
allethrins were found to be > 1500 mg/m3 (in the mouse and rat).
Allethrin is a Type I pyrethroid. The Type I syndrome involves
hyperactivity, tremors, convulsion, and paralysis in mammals and
insects (see Appendix).
Bioallethrin and esbiothrin are classified as compounds
producing mild primary irritation of the skin of New Zealand White
rabbits and slight irritation of the eyes.
When a 10% olive oil solution of allethrin was applied to the
eyes of rabbits, slight hyperaemia of the conjunctiva and eye
discharge were observed 10 min and 2 h after application,
respectively.
When a 5% olive oil solution of allethrin was applied to the
skin of guinea-pigs, every other day, 10 times in all, and animals
were challenged with an intradermal injection 2 weeks after the
last application, there was no sensitization reaction, but slight
lymphocytic and monocytic infiltration of the dermis was noted.
No adverse reactions were observed when the primary dermal
irritancy of S-Bioallethrin was evaluated in Wistar rats and Nagano
white rabbits.
When rats were fed allethrin in the diet at dose levels of up
to 10 000 mg/kg for 16 weeks, tremor and convulsions were noted at
10 000 mg/kg, but no gross effects were seen at 5000 mg/kg.
Allethrin was administered orally, using a syringe, to rats at
dose levels of up to 1000 mg/kg body weight per day, once a day, 6
days a week for 12 weeks. Half of the rats died following a single
administration of 1000 mg/kg. Higher relative weights of the
liver, thyroid, and kidney were noted at lower doses.
Inhalation of allethrin by mice at a level of 3 g/m3 for 4 h a
day, 6 days a week, over 4 weeks, resulted in eye discharge in all
animals. Histopathological examination of the lungs revealed
bronchopneumonia.
S-Bioallethrin was also tested via the inhalation route in
several studies conducted on mice and rats at a range of dose
levels (10, 20, or 25 times the normal concentration used) for
exposure periods of up to 5 weeks. The results of these studies
indicated that the short-term toxicity of S-Bioallethrin is low.
Bioallethrin was administered in the diet to rats for 90 days
at levels of 500, 1500, 5000, or 10 000 mg/kg. Slight or moderate
decreases in body weight gain and slight liver dysfunction were
found at the 5000 and 10 000 mg/kg levels. A no-observed-adverse-
effect level of 1500 mg/kg was determined.
When the same compound was administered in the diet of dogs,
for 6 months, at levels of 200, 1000, or 5000 mg/kg, general body
trembling, irregular heart rhythm, and increases in the mean levels
of alkaline phosphatase and SGPT were noted at the 5000 mg/kg
level. Hepatocellular degeneration was found at both the 1000 and
5000 mg/kg levels. A no-observed-adverse-effect level of 200 mg/kg
was established.
F344 rats were administered d-allethrin at levels of 0, 125,
500, or 2000 mg/kg diet for 123 weeks. Decreased body weight and
hepatotoxic effects were observed at levels exceeding 500 mg/kg
diet (i.e., 24.5 mg/kg body weight per day). However, no oncogenic
effects were observed at any dose and the no-observed-adverse-
effect level was 5.9 mg/kg body weight per day.
Dogs were fed allethrin at a rate of 50 mg/kg body weight per
day for 2 years. There were no compound-related gross or
microscopic changes at this level.
Allethrin, bioallethrin, esbiothrin, and S-Bioallethrin have
been evaluated in a variety of mutagenicity tests, including in
vitro/in vivo gene mutation, DNA damage and repair, and in vitro/in
vivo chromosomal aberrations. The results of all studies were
assessed as negative.
Allethrin, bioallethrin, and S-Bioallethrin were tested for
embryotoxicity and teratogenicity in rats, mice, and rabbits. No
compound-related embryo toxicity or teratogenicity were observed in
these studies, though some variations were observed in some
studies.
S-Bioallethrin did not seem to induce any disorders in the
fetuses of pregnant Wistar rats at doses of 100 mg/kg per day, or
less. Furthermore, S-Bioallethrin did not induce any teratogenic
effects in the pregnant TVCS mice at the maximum tolerated dose of
100 mg/kg per day.
Allethrin was administered daily in corn oil, by gavage, at
doses of 0, 215, or 350 mg/kg body weight to pregnant albino
rabbits from day 6 to day 18 of gestation. No fetotoxic or
teratogenic effects were observed.
1.7 Effects on Organisms in the Environment
Allethrin, bioallethrin, and S-Bioallethrin are all toxic for
fish with LC50 values of 9 - 90 µg/litre, S-Bioallethrin being the
most toxic. Allethrin is generally less toxic for Daphnia and
aquatic insect larvae with LC50 values of 150 - 50 000 µg/litre.
The toxicity of allethrin is low for birds (LD50 > 2000
mg/kg), but high for honey-bees (LD50 3 - 9 µg/bee).
2. IDENTITY, PHYSICAL AND CHEMICAL PROPERTIES, ANALYTICAL METHODS
2.1 Identity
CH3 CH3 CH3
\ / |
C C
/ \ / \\
(CH3)-C=CH-CH-CH-COO-CH C-CH2-CH=CH2
| |
CH2 - C
\\
O
Allethrin, the first of the synthetic pyrethroids, was
discovered by Schechter et al. (1949), when simplifying the chemical
structures of natural pyrethrins. It is a mixture of 8 stereo
isomers (Fig. 1) and is less volatile and more stable to heat and
light than the natural pyrethrins.
The 3S:3R or cis:trans ratio is reported to be 1:1 and the
optical ratio of 1R:1S in the acid and allethronyl moiety is also
1:1 (racemic). Technical grade material contains 75 - 95%
allethrin. d-Allethrin is the ester of the (1R, cis, trans)-acid
with racemic allethrolone. Bioallethrin and esbiothrin are the
(1R, trans)-acid ester of racemic allethrolone. S-Bioallethrin is
the ester of the (1R, trans)-acid with (1S)-allethrolone. The
compositions of these isomers are shown in Table 1.
Table 1. Chemical identity of allethrins of various stereoisomeric compositions
---------------------------------------------------------------------------------------------------------------------
Common name/CAS CA Index name (9CI) Stereoisomeric Synonyms and
Registry No./NIOSH compositiond trade names
Accession No.a Stereospecific nameb,c
---------------------------------------------------------------------------------------------------------------------
Allethrine 2-methyl-4-oxo-3-(2-propenyl)-2-cyclo- (1):(2):(3):(4) Pallethrin, Pynamin, Allycinerin,
584-79-2f penten-1-yl 2,2-dimethyl 3-(2-methyl-1- :(5):(6):(7):(8) Pyresin, Pyresyn, Necarboxylic acid,
GZ1476000 propenyl) cyclopropanecarboxylate (9CL) =1:1:1:1:1:1:1:1 ENT17, 510, FDA1446, FMC249, NIA249,
RU 28173
(RS)-3-Allyl-2-methyl-4-oxocyclopent- Allethrin concentrate MGK
2-enyl (1RS, cis, trans)-2,2-dimethyl-
3-(2,2-dimethylvinyl)cyclopropane-
carboxylate
or
(RS)-Allethronyl (1RS, cis, trans)-
chrysanthemate
d-Allethrin same as allethrin (1):(2):(3):(4) d-cis, trans-Allethrin
=4:4:1:1 Pynamin Forte
(RS)-Allethronyl [1R, cis, trans]-
chrysanthemate
Bioallethrin same as allethrin (1):(2)=1:1 d-trans-allethrin
584-79-2f (S)-Allethronyl[1R,trans] (+)-trans-allethrin,
GZ1950000 chrysanthemate depallethrine;
trans-allethrin
Bioallethrin(e)R;
D-TransR
Bioallethrin S- same as allethrin (1):(2)=1:3 sinbioallethrin;
cyclopentenyl (RS)-Allethronyl espedallethrine;
isomer [1R, trans] S-bioallethrin,
28434-00-6 chrysanthemate EsbiolR;
Esbiothrin(e)R
S-Bioallethrin same as allethrin (2) Esbiol, Esdepallethrin
28434-00-6 d-Allethronyl
GZ1472000 (S)-Allethronyl [1R, trans]- d- trans allethrin
chrysanthemate (+)-Allethronyl
(+)- trans-allethrin
RU 16121
---------------------------------------------------------------------------------------------------------------------
Table 1. (contd.)
---------------------------------------------------------------------------------------------------------------------
Common name/CAS CA Index name (9CI) Stereoisomeric Synonyms and
Registry No./NIOSH compositiond trade names
Accession No.a Stereospecific nameb,c
---------------------------------------------------------------------------------------------------------------------
- same as allethrin - d- cis-Allethrin
- (+)- cis-Allethrin
GZ1460000 (RS)-Allethronyl [1R, cis]-
chrysanthemate
- same as allethrin - -
-
GZ1925000 (S)-Allethronyl [1R, cis, trans]-
chrysanthemate
---------------------------------------------------------------------------------------------------------------------
a NIOSH (1983).
b (1R), d, (+) or (1S), 1, (-) in the acid part of allethrin signifies the same stereospecific conformation,
respectively. (S), d, (+) or (R), 1, (-) in the alcohol part of allethrin signify the same stereospecific
conformation, respectively.
c Allethronyl radical is a name of the radical that forms the alcohol part of allethrin. Chrysanthemic acid is a
name of the acid that forms the acid part of allethrin.
d Numbers in parentheses identify the structures shown in the figures of stereoisomers.
e ISO common name: common names for pesticides and other agrochemicals approved by the Technical Committee of the
International Organization for Standardization.
f CAS Registry No. 584-79-2 is assigned to both allethrin and bioallethrin.
The technical product (Esbiol) contains 90% S-Bioallethrin.
2.2 Physical and Chemical Properties
Some physical and chemical properties of allethrins are given
in Table 2.
Data on melting points were not available. Allethrin is
unstable to light and air and under alkaline conditions. However,
it is more stable on exposure to heat and light than pyrethrins.
Allethrin is decomposed by rapid pyrolysis at over 400 °C, but
vaporizes without decomposition (28 - 35%) when heated at 150 °C.
d-Allethrin is soluble in most organic solvents. d-Allethrin,
bioallethrin, and S-Bioallethrin are also unstable to light, in
air, and under alkaline conditions. S-Bioallethrin is miscible
with most organic solvents (FAO/ WHO, 1965; Martin & Worthing,
1977; Meister et al., 1983; Worthing & Walker, 1983; Devaux &
Bolla, 1986a,b; Devaux & Tillier, 1986).
Table 2. Physical and chemical properties of allethrins
------------------------------------------------------------------------------------------
Allethrin d-Allethrin Bio- Esbiothrin S-Bio-
allethrin allethrin
------------------------------------------------------------------------------------------
Physical state oil oily viscous viscous liquid
liquid liquid liquid
Colour pale - amber yellow yellow
yellow
Odour - - aromatic - -
Relative molecular mass 302.45 302.45 302.45 302.45 302.45
Boiling point (°C) 140 - 153 - -
(0.1 mmHg) (0.4mmHg)
Flash point (°C) - 130 65.6 - -
Solubility in water low low lowa low low
Solubility in organic solubleb soluble solublec soluble soluble
solvents
Density d251.005 d201.005 - d200.997 - d200.980
4 4 1.015 4 4
Vapour pressure 1.2 x 10-4 - 3.3 x 10-4 - -
mmHg (30 °C) mmHg (25 °C)
n-Octanol/water - - 4.8 x 104 - -
partition coefficient (25 °C)
------------------------------------------------------------------------------------------
a 4.6 mg/litre at 25 °C.
b Methanol (> 1 kg/kg), hexane (> 1 kg/kg), xylene (> 1 kg/kg), acetone, carbon
tetrachloride, kerosene, petroleum.
c Acetone, ethanol, hexane, methylene chloride, kerosene.
2.3 Analytical Methods
A limited number of publications is available on methods of
analysis for allethrin residues and analysis of environmental
media. Analytical procedures listed in Table 3 include (a)
extraction with solvent, (b) partition, (c) clean up, (d) suitable
analytical instruments and conditions, and (e) minimum detectable
concentration and recovery for each method.
The stereoselectivity of a radioimmunoassay (RIA) system using
an S-Bioallethrin-specific antiserum was studied by observing the
abilities of the 8 allethrin isomers and other selected compounds
to compete with a radiolabelled S-Bioallethrin tyramine derivative
for antibody-binding sites (Wing & Hammock, 1979). The results
demonstrate the feasibility of RIA as a rapid, sensitive, and
stereoselective residue technique for compounds difficult to
analyse using classical methods.
Table 3. Analytical methods for allethrina
-----------------------------------------------------------------------------------------------------------------------------
Sample Sample preparation Determination Limit of % Recovery Reference
Extraction Partition Clean-up method Derivatization Detection detection (fortification)
solvent method (mg/litre) (mg/litre)
-----------------------------------------------------------------------------------------------------------------------------
Analysis for Residues
Milk petroleum mercuric colori- 0.1 McClellan & Moore
oxide/ metric (1958)
Meat ether sulfuric
acid
Wheat petroleum modified colori- Desmarchelier
spirit Deniges metric (1976)
reagent (584 nm)
Analysis for total content
Dish n-hexane n-hexane/ HPTLC benzene/ dual-wave- 91-104% (300 µg) Uno et al. (1982)
CH3CN CCl4 (1 + 1) length
Apple n-hexane/ether/ densitometry 98% (300 µg)
Spinach formic acid (1 = 370 nm; 92% (300 µg)
(dis- (70/30/1) 2 = 230 nm)
lodgeable
residue)
Mosquito toluene FID-GC 94-102% Sakaue et al.
coil +99% (1985)
formic
acid (5:1)
Product analysis
Technical acetone FID-GC, N2 Murano (1972)
grade 40 ml/min,
1 m; 5% DEGS,
180 °C, 8.4
min
-----------------------------------------------------------------------------------------------------------------------------
a FID = Flame ionization detector; GC = gas chromatography; UV = ultraviolet; HPTLC = high-performance thin-layer
chromatography.
3. SOURCES IN THE ENVIRONMENT, ENVIRONMENTAL TRANSPORT, DISTRIBUTION
AND TRANSFORMATION, ENVIRONMENTAL LEVELS AND HUMAN EXPOSURE
3.1 Industrial Production
Allethrin is prepared by the esterification of [1RS, 3RS
or cis, trans]-2,2-dimethyl-3-(2,2-dimethylvinyl)
cyclopropanecarboxylic acid or chrysanthemic acid with (1RS)-3-
allyl-2-methyl-4-oxocyclopent-2-ene-1-ol or allethrolone (Sanders &
Taff, 1954).
It was first marketed in 1952, in Japan and the USA (Yoshioka,
1980). At present, several hundred tonnes are thought to be
manufactured annually throughout the world, mainly for the control
of household insect pests. Bioallethrin was first marketed in
early 1970 and is now used at a rate of 10 - 30 tonnes per year.
Formulations of allethrin combined with organophosphorus
insecticides, such as tetrachlorvinphos and fenitrothion, are
produced for agricultural use (Japan Plant Protection Association,
1984).
3.2 Use Patterns
Allethrin is used mainly for the control of flies and
mosquitoes in the home, flying and crawling insects on farm
animals, and fleas and ticks on dogs and cats. It is formulated as
aerosols (1 - 6 g/litre), sprays, dusts (1%), smoke coils, and
mats. It is used alone or combined with synergists (e.g.,
piperonyl butoxide and N-octylbicycloheptene dicarboximide) or
other insecticides (e.g., fenitrothion). It is also available in
the form of emulsifiable concentrates (810 g/kg) and wettable
powders. Synergistic formulations (aerosols or dips) have been
used on fruits and berries, post-harvest, in storage, and in
processing plants. Post-harvest use on stored grain (surface
treatment) has also been approved in some countries (FAO/WHO 1965).
No information is available on recent post-harvest treatment with
allethrin.
Bioallethrin is more than twice as effective as allethrin and
is mainly used to control household insects. It is formulated as
aerosols and sprays with synergists and/or other insecticides
(e.g., d-phenothrin or deltamethrin). A few tonnes of bioallethrin
have been used in Spain for this purpose, according to Battelle
(1982). Since 1982, this aerosol formulation has been used in many
other countries. The use of mosquito coils and electric mats has
also increased considerably.
S-Bioallethrin is several times as effective as allethrin
against flying and crawling insects and is mainly used in industry
and in the home. It is formulated as aerosols and sprays with
synergists for use as a knock-down or flushing agent. Several
tonnes of S-Bioallethrin were used for this purpose in 1980 in
France, together with bioallethrin and allethrin (Battelle, 1982).
3.3 Environmental Transport, Distribution, and Transformation
Degradation pathways of allethrin are summarized in Fig. 2.
When exposed as a thin film or coating on glass (2.6 µg/cm2) to
a sunlamp for 8 h, [14C]- trans-allethrin was rapidly decomposed to
give at least 14 products. The photoproducts derived from the
carboxy (acid) - and allethrolone (alcohol) - labelled compounds
showed a similar TLC pattern, indicating that most, if not all, of
the products were esters. Saponification of the mixture of esters
liberated 16 acids including trans-carbonic acid and keto
derivatives arising from the oxidative attack at the double bond of
the isobutenyl moiety, and chrysanthemic acid derivatives having
the trans-methyl in the isobutenyl side chain oxidized to the
alcohol, aldehyde and carboxylic acid. There was no cis/trans-
isomerization, even after extended irradiation for up to 24 h (Chen
& Casida, 1969).
The photodegradation rates of a thin film (54 µg/cm2) under a
sunlamp were compared for trans-allethrin, pyrethrin-I,
tetramethrin, and dimethrin. The rates of transformation varied
dramatically with variation in the alcohol moieties, and the
exposure times needed for 90% loss of the original compound were
approximately 0.2, 4, 8, and 16 h, for pyrethrin-I, tetramethrin,
allethrin, and dimethrin, respectively. The chemical reactions
involved in the alcohol moieties were not clarified (Chen & Casida,
1969).
The photostability under sunlight of bioallethrin included in,
or mixed with, beta-cyclodextrin was studied. Inclusion slowed
down the decomposition of allethrin, the half-life extending from
3 days for the free state to about 35 days for the included form.
Inclusion retarded the photochemical decomposition of the acid
moiety, compared with the alcohol moiety (Yamamoto et al., 1976).
Irradiation of a diastereomer mixture of bioallethrin in
hexane or kerosene, using a medium or high pressure mercury arc
lamp, resulted in the formation of the cyclopropylrethronyl
chrysanthemates (13,15 in Fig. 2) (approx. 90%) via di-pi-methane
rearrangement at the allyl substituent in the alcohol moiety
(Fig. 2). The same product was formed in kerosene and in sunlight.
The reaction was completely quenched by 2,5-dimethylhexa-2,4-diene.
No evidence was obtained of the accompanying formation of either
cis-cyclopropane- or 3,3-dimethylacrylic esters (Bullivalent &
Pattenden, 1973; Kawano et al., 1980).
S-[14C]-Bioallethrin labelled in the acid moiety was rapidly
decomposed, when exposed to sunlight as a thin film (25 µg/cm2) on
glass. After 3 h, with 56% of the compound converted, the major
products identified resulted from ester cleavage (18) (14.7%),
oxidation at the isobutenyl methyl group (14) (7.9%), di-pi-methane
rearrangement (15) (9.9%), epoxidation at the isobutenyl double
bond (16,17) (16%), and cis/trans-isomerization (10) (1.2%). Many
minor photoproducts, totalling 55% of the reaction mixture, were
not identified. Sunlight photolysis in solution (1.8 - 7.2 x
10-3 mol/litre) for 3 h yielded most of the products observed in
the solid phase. More epoxides (17) were formed in benzene (33%)
than in hexane (12%), and in aerated solutions than in solutions
saturated with argon or nitrogen. In acetonitrile-water (4:1),
S-Bioallethrin reacted to form cyclopropylrethronyl chrysanthemate
(15) (70%), a cis/trans-isomerization product (10) (14%), and
epoxides (17) (8%) in the acid moiety. Formation of chrysanthemic
acid (18) by ester bond cleavage was comparable in all solvents
(4 - 6%) but was increased in the presence of a benzil radical
(Ruzo et al., 1980).
Direct photolysis of S-Bioallethrin in benzene under UV
radiation (360 nm) yielded the products observed under sunlight,
together with trace amounts of the decarboxylated derivative (11),
the cis-epoxides, and more than twenty-five other minor products.
Triplet intermediates were involved in the cyclopropane
isomerization and the di-pi-methane rearrangement, since the
reactions were enhanced by a sensitizer benzophenone, especially
at a high concentration (0.1 mol/litre), and were blocked by
1,3-cyclohexadiene. The epoxides formed by triplet oxygen were
considerably enhanced by the addition of a benzil radical, and were
the only major products in the presence of 1,3-cyclohexadiene.
Oxidation at the trans-methyl group in the chrysanthemate moiety
resulted from radical reactions of ground-state oxygen. Singlet
oxygen was not involved in these oxidation reactions since the
sensitizer, Rose Bengal, gave a totally different product
distribution under UV radiation. Under comparable conditions, the
cyclopropylrethronyl chrysanthemate (15), formed via di-pi-methane
rearrangement, reacted in benzene under UVR (360 nm) more slowly
than the parent compound, yielding the corresponding epoxides (16)
(15%) and allethrin (9) (70%) (Ruzo et al., 1980).
The rapid pyrolysis of allethrin and other chrysanthemic esters
was examined by gas-liquid chromatography (GLC) with a less stable
sample injection port heated at 250 - 550 °C. Allethrin was than
any of the other compounds, including tetramethrin, at temperatures
of over 400 °C, because of the instability of the allethrolone
moiety (Kyogoku et al., 1970).
Allethrin in a pyrex glass tube heated at 400 °C, under
nitrogen, gave chrysanthemic acid, 2,6-dimethylhepta-2,4-diene (21)
and pyrocin (22) as pyrolysis products from the acid moiety, and
2,7-diallyl-3,6-dimethyl-1-indanone (25) and 2,4-diallyl-3,5-
dimethyl-1-indanone (26) from the alcohol moiety (Nakada et al.,
1971).
Baba & Ohno (1972) studied the vaporization and degradation of
allethrin (100 mg) in an aluminum foil vessel in air at 150 °C for
9 h. Under these conditions, 28 - 35% of allethrin vaporized
without undergoing any changes, 24 - 45% polymerized, and 18 - 40%
decomposed. The thermal degradation products formed were trans-
chrysanthemic acid (18) and allethrolone (20), together with
2-allyl-3-methylcyclopenta-2-ene-1,4-dione (24), which was formed
by subsequent pyrolysis of allethrolone. In addition, cis-
chrysanthemic acid (19), pyrocin (22), and cis-dihydrochrysanthemo-
delta-lactone (23) were formed under the same conditions from the
mixture of 8 isomers of allethrin; cis-dihydroxy-chrysanthemo-
delta-lactone (23) was produced from cis-allethrin.
3.4 Environmental Levels and Human Exposure
No information is available on levels of allethrins in the
environment or on general population or occupational levels of
exposure.
3.4.1 Residues in food
No information is available on the levels of allethrin residues
in treated crops. Allethrin was not detected (detection limit
0.1 mg/kg) in the milk of dairy cows that had been sprayed daily
for 3 weeks or in the meat tissue of a female goat that had been
sprayed daily for 5 weeks, all animals receiving a large overdose
of spray. No information is available on the chemical nature of
the terminal residues in treated crops (FAO/WHO, 1965).
4. KINETICS AND METABOLISM
4.1 Metabolism in Mammals
Metabolic pathways of allethrin in mammals are summarized in
Fig. 3.
When allethrin (9) labelled with 14C in the acid moiety or with
3H in the alcohol moiety was administered orally to male Sprague
Dawley rats at levels ranging from 1 to 5 mg/kg body weight, the
radiocarbon and tritium from the acid- and alcohol-labellings were
eliminated in the urine (30% and 20.7%, respectively) and faeces
(29% and 27%, respectively) in 48 h. The tissue residues were not
determined. Most of the metabolites excreted in the urine were
ester-form metabolites together with two hydrolysed products,
chrysanthemum dicarboxylic acid (29) (CDCA) and allethrolone (20).
The faecal metabolites were not identified. Allethrin could have
been metabolized via any of the following 5 biotransformation
pathways; hydrolysis to allethrolone and to a smaller extent CDCA,
formation of the 2,3-diol (30) from the allyl moiety, hydroxylation
at the methylene position of the allyl grouping (31), hydroxylation
at one of the geminal dimethyl groups (32), and oxidation at the
trans methyl group of the isobutenyl moiety to carboxylic acid (28)
(Elliott et al., 1972a,b; Yamamoto, 1970).
4.2 Enzymatic Systems for Biotransformation
The microsome or microsome-plus-soluble fraction prepared from
rat or mouse liver homogenate was incubated in a phosphate buffer
(0.1 mol/litre, pH 7.4) for 30 min at 37 °C with 7 or 70 µg
allethrin, in the presence or absence of NADPH. Allethrin yielded
neutral metabolites (ex. 14, 27), several acidic metabolites
(ex. 28, 29), and some other polar metabolites, when examined using
two-dimensional thin-layer chromatography (Elliot et al., 1972a,b).
5. EFFECTS ON ORGANISMS IN THE ENVIRONMENT
Acute toxicity data on allethrin in aquatic and terrestrial
non-target organisms are summarized in Tables 4 and 5,
respectively.
5.1 Aquatic Organisms
Allethrin, bioallethrin, and S-Bioallethrin are all toxic
for fish, with LC50 values ranging from 9 to 90 µg/litre, as
shown in Table 4.
The biological activity in fish is affected by temperature.
The toxicity of 1R or (+)- trans-allethrin for the bluegill was
about 1.5 times higher at 22 °C than at 12 °C (Mauck et al., 1976).
Water hardness and pH did not have any significant effects on the
toxicity for fish (Mauck et al., 1976).
Allethrin is generally less toxic in arthropods than in fish,
with the exception of the stonefly, which is the most susceptible
insect, having a 96-h LC50 of 2 µg/litre, as shown in Table 4.
5.2 Terrestrial Organisms
Only a few data on terrestrial organisms are available. The
toxicity of allethrin is low for birds and high for honey-bees, as
has been observed for other pyrethroids (Table 5).
Table 4. Acute toxicity of allethrin for non-target aquatic organisms
--------------------------------------------------------------------------------------------------------------------------------------
Species Size Parameter Concentra- Formula- System Tempera- pH Hardness (mg Reference
tion (µg/ tiona ture (°C) CaCO3/litre)
litre) or salinity (%)
--------------------------------------------------------------------------------------------------------------------------------------
Fish
Salmon ( Salmo salar) 10 cm; 96-h LC50 16.5 technical renewal 10 Zitko et al. (1977)
11.07 g
Coho salmon 96-h LC50 22.2 (+)-trans static 12 Mauck et al. (1976)
( Oncorhynchus 96-h LC50 9.40 (+)-trans flow- 12 Mauck et al. (1976)
kisutch) through
Killifish ( Oryzias adult 48-h LC50 87 technical static 25 Miyamoto (1976)
latipes) adult 48-h LC50 50 (+)- trans static 25 Miyamoto (1976)
adult 48-h LC50 42 (+)- cis static 25 Miyamoto (1976)
adult 48-h LC50 32 (+),(+)-t static 25 Miyamoto (1976)
Rainbow trout ( Salmo 24-h LC50 20 technical static Cope (1965)
gairdneri) 48-h LC50 19 technical static Anon. (1968)
Steelhead trout 96-h LC50 17.5 (+)-trans static 12 Mauck et al. (1976)
( Salmo gairdneri) 96-h LC50 9.70 (+)-trans flow- 12 Mauck et al. (1976)
through
Channel catfish 96-h LC50 >30.1 (+)-trans static 12 Mauck et al. (1976)
( Ictalurus panctatus) 96-h LC50 27.0 (+)-trans flow- 12 Mauck et al. (1976)
through
96-h LC50 14.6 (+),(+)-t flow- 12 Mauck et al. (1976)
through
Yellow perch ( Perca 96-h LC50 9.90 (+)-trans flow- 12 Mauck et al. (1976)
flavescens) through
96-h LC50 7.80 (+),(+)-t static 12 Mauck et al. (1976)
Fathead minnow 96-h LC50 80.0 (+),(+)-t static 12 Mauck et al. (1976)
( Pimephales promelas) 96-h LC50 53.0 (+),(+)-t flow- 12 Mauck et al. (1976)
through
--------------------------------------------------------------------------------------------------------------------------------------
Table 4. (contd.)
--------------------------------------------------------------------------------------------------------------------------------------
Species Size Parameter Concentra- Formula- System Tempera- pH Hardness (mg Reference
tion (µg/ tiona ture (°C) CaCO3/litre)
litre) or salinity (%)
--------------------------------------------------------------------------------------------------------------------------------------
Fish (contd.)
Bluegill ( Lepomis 0.8 g 96-h LC50 35.0 (+)-trans static 22 7.5 40 - 80 Mauck et al. (1976)
macrochirus) 0.8 g 96-h LC50 47.0 (+)-trans static 17 7.5 40 - 48 Mauck et al. (1976)
0.8 g 96-h LC50 56.0 (+)-trans static 12 7.5 40 - 48 Mauck et al. (1976)
0.8 g 96-h LC50 49.0 (+)-trans static 12 6.6 10 - 13 Mauck et al. (1976)
0.8 g 96-h LC50 49.0 (+)-trans static 12 7.8 160 - 180 Mauck et al. (1976)
0.8 g 96-h LC50 42.5 (+)-trans static 12 8.2 280 - 320 Mauck et al. (1976)
0.8 g 96-h LC50 56.0 (+)-trans static 12 6.5 40 - 48 Mauck et al. (1976)
0.8 g 96-h LC50 60.0 (+)-trans static 12 9.5 40 - 48 Mauck et al. (1976)
0.8 g 96-h LC50 27.6 (+),(+)-t static 17 7.5 40 - 48 Mauck et al. (1976)
0.8 g 96-h LC50 33.2 (+),(+)-t static 12 7.5 40 - 48 Mauck et al. (1976)
0.8 g 96-h LC50 39.0 (+),(+)-t static 12 6.6 10 - 13 Mauck et al. (1976)
0.8 g 96-h LC50 30.0 (+),(+)-t static 12 7.8 160 - 180 Mauck et al. (1976)
0.8 g 96-h LC50 36.0 (+),(+)-t static 12 8.2 280 - 320 Mauck et al. (1976)
0.8 g 96-h LC50 >25.0 (+),(+)-t static 12 6.6 40 - 48 Mauck et al. (1976)
0.8 g 96-h LC50 >25.0 (+),(+)-t static 12 9.5 40 - 48 Mauck et al. (1976)
Arthropods
Sigara substriata 0.59 cm; 48-h LC50 150 technical static 25 Nishiuchi (1981)
6.1 mg
Micronecta sedula 0.32 cm; 48-h LC50 420 technical static 25 Nishiuchi (1981)
1.8 mg
Cloeon dipterum 0.93 cm; 48-h LC50 350 technical static 25 Nishiuchi (1981)
5.6 mg
Orthetrum albistylum 2.3 cm; 48-h LC50 1500 technical static 25 Nishiuchi (1981)
speciosum 0.62 g
Eretes sticticus 1.5 cm; 48-h LC50 380 technical static 25 Nishiuchi (1981)
0.2 g
--------------------------------------------------------------------------------------------------------------------------------------
Table 4. (contd.)
--------------------------------------------------------------------------------------------------------------------------------------
Species Size Parameter Concentra- Formula- System Tempera- pH Hardness (mg Reference
tion (µg/ tiona ture (°C) CaCO3/litre)
litre) or salinity (%)
--------------------------------------------------------------------------------------------------------------------------------------
Sympetrum frequens 2.1 cm; 48-h LC50 1300 technical static 25 Nishiuchi (1981)
0.56 g
2.1 cm; 48-h LC50 2000 technical static 15 Nishiuchi (1981)
0.56 g
Sympetrum frequens 2.1 cm; 48-h LC50 2000 technical static 20 Nishiuchi (1981)
(contd.) 0.56 g
2.1 cm; 48-h LC50 850 technical static 30 Nishiuchi (1981)
0.56 g
Daphnia pulex 3-h LC50 > 50 000 technical static 25 Miyamoto (1976)
3-h LC50 > 50 000 (+)- cis static 25 Miyamoto (1976)
3-h LC50 25 000 - (+)- trans static 25 Miyamoto (1976)
50 000
3-h LC50 5 000 - (+),(+)-t static 25 Miyamoto (1976)
10 000
48-h EC50 21 Sanders & Cope (1966)
Stonefly ( Pteronarcys 48-h LC50 28 technical Anon. (1968)
californica) 3-3.5 cm 96-h LC50 2.1 technical static 15.5 7.1 Sanders & Cope (1968)
Gammarus lacustris 48-h LC50 20 Anon. (1968)
24-h LC50 38 Sanders (1969)
Simocephalus 48-h EC50 56 Sanders & Cope (1966)
serrulatus
--------------------------------------------------------------------------------------------------------------------------------------
a (+),(+)-t = (+)-allethronyl (+)- trans allethrin = S-Bioallethrin.
(+)- trans = (+)- trans-allethrin = bioallethrin.
(+)- cis = (+)- cis-allethrin.
Table 5. Acute toxicity of allethrin for non-target terrestrial organisms
-----------------------------------------------------------------------------------------
Species Size Application Toxicity Temperature Reference
(°C)
-----------------------------------------------------------------------------------------
Birds
Mallard young oral (in LD50 > 2000 Tucker & Crabtree (1970)
( Anas capsule) (mg/kg)
platyrhynchos)
Arthropods
Honey-bee ( Apis contact LD50 3.4 26 - 27 Stevenson et al. (1978)
mellifera) (µg/bee)
oral LD50 4.6-9.1 Stevenson et al. (1978)
(µg/bee)
-----------------------------------------------------------------------------------------
6. EFFECTS ON EXPERIMENTAL ANIMALS AND IN VITRO TEST SYSTEMS
6.1 Acute Toxicity
The acute oral toxicity of allethrin isomers for rats is
moderate to weak (378 - 2430 mg/kg) (Table 6). However, allethrin
injected intravenously in rats or intracerebrally in mice caused
severe poisoning syndrome with tremors.
Table 6. Acute oral toxicity of allethrin isomers
-------------------------------------------------------------------
Compound Animal Sex LD50 (mg/kg Reference
body weight)
-------------------------------------------------------------------
Allethrin rat M 2430 Miyamoto (1976)
rat F 720 Miyamoto (1976)
rat M 920 Carpenter et al. (1950)
rat F 900 Carpenter et al. (1950)
mouse M 500 Miyamoto (1976)
mouse F 630 Miyamoto (1976)
mouse M 480a Carpenter et al. (1950)
mouse F 1580b Carpenter et al. (1950)
rabbit M 4290 Carpenter et al. (1950)
Bioallethrin mouse M 330 Miyamoto (1976)
mouse F 350 Miyamoto (1976)
rat M 709 Audegond et al. (1979a)
rat F 1041 Audegond et al. (1979a)
S-Bioallethrin rat M 1290 Miyamoto (1976)
rat F 430 Miyamoto (1976)
rat M 574 Audegond et al. (1979c)
rat F 412 Audegond et al. (1979c)
mouse M 285 Miyamoto (1976)
mouse F 250 Miyamoto (1976)
d- cis-Allethrin mouse M 210 Miyamoto (1976)
mouse F 270 Miyamoto (1976)
Esbiothrin rat M 432 Audegond et al. (1979b)
rat F 378 Audegond et al. (1979b)
-------------------------------------------------------------------
a 20% in deodorized kerosene.
b 5% in deodorized kerosene.
When allethrin was applied to shaved skin on the backs of
Wistar rats (8 females and 6 males/group) or ddY mice (10 females
and 10 males/group) at dose levels of 2 g/kg body weight or 5 g/kg
body weight, 8 out of 16 mice treated with 5 g/kg died, but none of
the rats (Nakanishi et al., 1970).
Esbiothrin was applied to the shaved skin of New Zealand white
male and female rabbits at a level of 2000 mg/kg body weight. All
the animals showed erythema and, in some cases, an oedematous
reaction, but behaviour and body weight gain remained normal.
There were no compound-related deaths (Kaysen & Sales,1984).
The minimum toxic doses of d-allethrin (2-h exposure) and
S-Bioallethrin (3-h exposure) for rats and mice, exposed to each
compound in the form of a mist, were: d-allethrin, rats - 260
mg/m3, mice - 260 mg/m3, S-Bioallethrin, rats - 24 mg/m3, and mice
- 91 mg/m3 (Miyamoto, 1976).
Wistar male rats were exposed to atmospheres containing
bioallethrin at 500, 1000, or 2000 mg/m3 for 24 h. No deaths
occurred throughout the trial. The no-observed-adverse-effect
level via inhalation was 1000 mg/m3, which is about 3000 times
higher than the expected concentration under normal conditions of
use (Chesher & Malone, 1972a).
Wistar male and female rats were exposed to respirable droplets
of esbiothrin for a period of 4 h. There was no treatment-related
change in the number of survivors, but congestion of the lungs was
found in dead animals. The LC50 was 2630 mg/m3 (Hardy et al.,
1984).
Male and female ICR-JCL mice and Sprague-Dawley rats were
exposed to S-Bioallethrin in deotomisol via the inhalation route
for 2 h. The LC50 was approximately 1500 mg/m3 for mice and more
than 1650 mg/m3 for rats (Sakamoto et al., 1975c).
The acute inhalation toxicity (8 h/day for 3 consecutive days)
of the smoke from S-Bioallethrin mosquite coils was extremely low
for ICR mice and Sprague Dawley rats (Ogami et al., 1975). A smoke
concentration 60 times that normally found did not induce toxic
symptoms or death in either the mouse or the rat.
6.2 Short-Term Studies
6.2.1 Allethrin
Rats showed a slight decrease in growth rate when fed
commercial allethrin at a dietary level of 5000 mg/kg, while growth
rate was nearly normal when the same concentration of purified
allethrin was administered. It appeared that a dietary level of
2500 mg/kg did not produce any clinical effects. Examination of
the liver was not reported (Ambrose & Robbins, 1951). Rats fed
allethrin for 16 weeks did not show any gross effects at
5000 mg/kg, but showed tremors and convulsions at 10 000 mg/kg
(Lehman, 1952).
When allethrin was given to Wistar rats at dietary levels of
1000, 5000, and 15 000 mg/kg for 12 weeks, a decrease in body-
weight gain, an increase in liver or kidney weight ratio, and bile
ductule proliferation were seen at levels of 5000 mg/kg or more.
Similar observations were seen when 5000 mg 12 weeks S-Bioallethrin/
kg was administered to Sprague-Dawley rats for (Miyamoto, 1976).
Allethrin was administered via gastric intubation to male rats
(10 animals in each group) at dose levels of 0, 250, 500, or
1000 mg/kg body weight per day, for 6 days a week over 12 weeks.
At 1000 mg/kg, half the rats died following the first dose. No
abnormal signs were observed in the remaining dosage groups.
Higher relative weights of liver, thyroid (at 250 and 500 mg/kg),
and kidney (at 500 mg/kg) were observed. Histopathological
examination revealed papillary changes in the epithelium and
hypertrophy of epithelial cells in the thyroids of rats at both
250 and 500 mg/kg (Nakanishi et al., 1970).
Four male and four female dogs fed allethrin at a rate of
50 mg/kg per day over 2 years did not show any gross or microscopic
effects. Animals in other groups receiving higher doses suffered
convulsions, survival time was progressively shortened, and non-
specific pathological changes were observed (Lehman, 1965).
Rats (and dogs) withstood repeated inhalation of allethrin
aerosols in air at a concentration several times higher than levels
normally used. However, because of the method of administration,
it was not possible to measure intake as mg/kg body weight
(Carpenter et al., 1950).
Eight female mice inhaled allethrin at a level of 3 g/m3 for
4 h/day, 6 days a week, over 4 weeks. No deaths were observed.
Eye discharge was seen in all animals after each exposure
throughout the 4-week period. A slight, sporadic decrease in
activity was found from the third week. Histopathological
examination of the lungs of 5 mice showed bronchopneumonia
(Nakanishi et al., 1970).
6.2.2 d-Allethrin
A 90-day toxicity study was conducted on Wistar rats (male and
female) fed diets containing d-allethrin at 0, 750, 2000, or
4000 mg/kg. Increased liver weight was observed in animals
receiving 2000 mg/kg or more and glutamine-oxaloacetic- and
glutamine-pyruvic acid transaminase activities were raised in those
receiving 4000 mg/kg.
The no-observed-adverse-effect dietary level for d-allethrin
was 750 mg/kg diet (49.6 mg/kg body weight per day for male mice
and 59.2 mg/kg per day for females) (Kadota, 1972).
ICR mice and Sprague-Dawley rats (both male and female) were
exposed to a mist (particle diameter 1 - 2 µm, generated by means
of atomizer) of d-allethrin (123 mg/m3) or S-Bioallethrin (6.1,
16.9, or 61.3 mg/m3) for 3 h per day, 5 days per week, over 4 weeks
(Miyamoto, 1976). Mortality rates, behaviour, body and organ
weights, haematology, clinical biochemistry, and histopathology of
the organs were examined. Toxic symptoms, such as salivation and
tremors, were found only in groups administered d-allethrin at
123 mg/m3 and S-Bioallethrin at 61.3 mg/m3.
In a study by Kadota et al. (1974), ICR mice and Sprague-
Dawley rats were exposed to the smoke of mosquito coils containing
0.3% d-allethrin, at 20 times the conventional rate of application
(10 coils/24 m3), in a closed room for 8 h/day, 6 days/week over
5 weeks. There were no effects on body and organ weights, food
consumption, haematology, blood biochemistry, or histopathology.
6.2.3 Bioallethrin
Bioallethrin was given to groups of Wistar rats (16 males and
16 females) for 90 consecutive days at concentrations of 500, 1500,
5000, or 10 000 mg/kg diet (Wallwork et al., 1972). No marked
adverse effects were observed, except for a slight to moderate
decrease in body weight gain and slight liver dysfunction,
observed in the groups receiving 5000 and 10 000 mg/kg,
respectively. No dose-related macroscopic or microscopic changes
were observed. The no-observed-adverse-effect level for
bioallethrin in rats, after 90 days of treatment, was 1500 mg/kg
diet (equivalent to an intake of about 135 mg/kg body weight per
day).
Dogs were administered bioallethrin in the diet at
concentrations of 200, 1000, or 5000 mg/kg for 6 months (Griggs et
al., 1982). No animals died during the study. General body
trembling and irregular heart rhythm were noted at the highest dose
level. Body-weight gain was slightly reduced in males receiving
1000 mg/kg diet and in both sexes receiving 5000 mg/kg. Consistent
elevation in the mean levels of alkaline phosphatase was noted at
1000 and 5000 mg/kg in males, at 5000 mg/kg in females, and an
elevated SGPT at 5000 mg/kg was observed in both males and
females. No compound-related macroscopic changes were observed.
Histological investigation revealed hepatocellular degeneration in
both males and females in the groups receiving 1000 and 5000 mg/kg.
This was associated with intracanalicular and hepatocellular
pigmentation. Similar pigmentation was seen within the tubular
epithelium of the renal cortex. The no-observed-adverse-effect
level in this study was 200 mg/kg diet (equivalent to an intake of
6.1 and 7.2 mg/kg (1.6 ml) per day for males and females,
respectively).
No marked drug-related changes were observed in Wistar male
rats exposed through continuous inhalation to a concentration of
125 mg bioallethrin/m3 air, for 10 consecutive days (Chesher &
Malone, 1972b).
6.2.4 S-Bioallethrin
Groups of 10 Wistar rats (5 males and 5 females) were given
S-Bioallethrin in the diet for 90 days; groups of 20 animals
(10 males and 10 females) received S-Bioallethrin for 180 days
(Motoyama et al., 1975a). Males received S-Bioallethrin at dietary
levels of 3, 1, 0.3, or 0.1 g/kg, and females, at 1.5, 0.3, 0.1, or
0.05 g/kg. The differences in the doses between the sexes were due
to the results of an acute toxicity study in which the LD50 for
males was about 300 mg/kg and that for females, about 170 mg/kg.
Abnormal symptoms were not observed, and deaths did not occur in
either study. No macroscopic abnormal changes were observed.
Histological investigation did not show any compound-related
lesions, only scattered changes, which also occurred in the
untreated groups and did not show any regular tendency.
S-Bioallethrin did not induce any toxic effects in the males
receiving the highest dose (3 g/kg) or in the females receiving the
highest dose of 1.5 g/kg. The calculated doses of S-Bioallethrin
for the males were about 330 mg/kg body weight in the early stages
of the study and 200 mg/kg body weight in the later stages; the
females received about 120 and 100 mg/kg body weight.
JLC-ICR mice and Sprague-Dawley rats were exposed for 2 h/day,
6 days a week, for a month to concentrations of S-Bioallethrin in
deotomisol of 20 mg/m3, 80 mg/m3, or 160 mg/m3. The lowest
concentration was well tolerated. At 80 mg/m3 and 160 mg/m3, toxic
signs, such as excitation, tail raising, jumping, salivation, and
slight trembling occurred in the mice and slight salivation and
nasal haemorrhage, in the rats. No changes were observed in
haematological and biochemical tests or microscopically.
S-Bioallethrin seemed to be more toxic in the mouse (1 death/24 at
80 mg/m3 and 4 deaths/24 at 160 mg/m3) than in the rat (no deaths)
(Sakamoto et al., 1975d).
In a further study by Sakamoto et al. (1975b), JCL-ICR mice and
JCL Sprague-Dawley rats were exposed for 8 h/day, 6 days a week,
for 5 weeks to the smoke containing S-Bioallethrin emitted from
5 or 10 mosquito coils per 9.9 m2 room area. The atmospheric
concentrations produced were more than 10 or 20 times greater than
would be found under normal conditions of use. Toxic effects were
not observed in either the mouse or the rat and there were no
deaths. The results indicate that the short-term inhalation
toxicity of the fumes from S-Bioallethrin mosquito coils is
extremely low (Sakamoto et al., 1975b).
Two studies with an S-Bioallethrin electric mosquito mat were
performed on mice. Animals were exposed for 8 h per day, 6 days a
week over 4 weeks, to fumes that were 25 or 10 times the
concentration normally used. As treated animals in the first study
showed encephalitis, a second study was performed to check whether
the pathological changes were a specific effect of the product or a
viral infection. Encephalitis did not occur in any of the treated
animals (160 animals treated instead of 40) in the second study.
Slight circulatory disorders in the brain and lungs and slight
inflammation of the lungs were observed only in animals exposed to
25 times the normal concentration. The possibility that
encephalitis was a specific effect of S-Bioallethrin was therefore
dismissed (Tsuchiyama et al., 1975).
6.3 Primary Irritation
6.3.1 Eye irritation
Two solutions of allethrin dissolved in olive oil (10% and 50%)
were prepared. One tenth ml of solution was applied to one eye of
each test rabbit. Both dosages of allethrin produced eyelid-
closure, slight conjunctival hyperaemia at 10 and 30 min,
respectively, after application, and eye discharge 2 h after
application. Lachrymation was also observed in the group treated
with the 50% solution from 0.5 to 2 h after application (Nakanishi
et al., 1970).
The effects of 0.1 ml undiluted esbiothrin were evaluated in 9
male albino New Zealand rabbits using the Draize test method and
classified according to irritation potential by the Kay and
Calandra scale, as modified by Guillot (Audegond et al., 1984b).
The compound was classified as slightly irritant in both rinsed and
unrinsed eyes.
When 0.1 ml undiluted S-Bioallethrin and 0.1 ml 50% solution of
S-Bioallethrin in corn oil were applied to the eyes of male
Japanese white rabbits, only slight eye irritation occurred
(Sakamoto et al., 1975a). Symptoms included nictitation,
hyperaemia of the conjunctiva, and tears. No abnormalities of the
iris or cornea were observed.
6.3.2 Skin irritation
Undiluted technical allethrin (0.5 ml) or a 20% solution in
olive oil (2.5 ml) were applied to the dorsal skin of rabbits. No
differences were observed between allethrin-treated rabbits and the
untreated controls (Nakanishi et al., 1970).
The dermal irritancy of a mixture of 4% bioallethrin and 20%
piperonyl butoxide in an odourless petroleum distillate was
evaluated on the intact and abraded skin of 3 California female
rabbits, using the Draise test method. Virtually no reaction was
produced on the intact skin, but increases in the degree of
erythema and the duration of reaction were observed on the abraded
skin. However, by 6 days, all treated sites were normal. Thus,
bioallethrin was classified as mildly irritating on abraded skin
(Vercoe & Malone, 1969).
In a similar study, the dermal irritancies of bioallethrin and
of esbiothrin were determined on the intact and abraded skin of the
rabbit, according to the Draize method (Motoyama et al., 1975b).
Both compounds were found to be slightly irritant.
The primary dermal irritancy of a 5 ml dose of esbiothrin was
evaluated over a 7-day test period on the intact and abraded skin
of 6 male, albino New Zealand rabbits using the Draise test method.
An increase in the degree of erythema was observed in both the
intact and abraded skin, but by 7 days all treated sites were
normal. Thus, esbiothrin was classified as slightly irritant
(Audegond et al., 1984a).
In a study by Motoyama et al. (1975b), the primary dermal
irritancy of S-Bioallethrin was evaluated for 72 h on the intact
skin of 5 male and 5 female Wistar rats and 3 groups of 3 male and
3 female Nagano white rabbits. The doses administered to the rats
included undiluted S-Bioallethrin and dilutions of 5 or 25 times in
corn oil. The doses administered to the rabbits included undiluted
S-Bioallethrin and dilutions of 10 or 100 times in corn oil. No
changes were observed in the dermis of either the rat or the
rabbit, at any dose level.
S-Bioallethrin produced mild primary irritation of the intact
skin and the skin surrounding an abrasion in New Zealand white
rabbits (details of the study not given in the report) (Fisch,
1974).
6.4 Sensitization
One half ml of a 5% olive oil solution of allethrin was applied
topically to the backs of male guinea-pigs, every other day, 10
times. Two weeks after the last application, the animals were
challenged with a similar application of allethrin. Only a
sporadic pinkish colour was observed (same degree as vehicle
control) at the site of application. Histopathological examination
revealed slight lymphocytic and monocytic infiltration of the
dermis in the allethrin-treated group (Nakanishi et al., 1970).
The sensitizing properties of a 10% solution of bioallethrin in
petroleum distillate were evaluated in the Stevens ear-flank test
in 2 groups of 10 male albino guinea-pigs (Saunders & Vercoe,
1970). Bioallethrin did not produce any irritation, but produced
slight sensitization.
6.5 Long-term Studies and Carcinogenicity
When Wistar rats were exposed to racemic allethrin (dietary
levels of 500, 1000, or 2000 mg/kg) for 80 weeks, bile duct
proliferation was seen at levels of 1000 mg/kg or more and a
decrease in glutamine-oxaloacetic acid transaminase activity was
seen at 2000 mg/kg. However, no oncogenic effects were observed at
any dose level (Miyamoto, 1976).
F344 rats (male and female) were fed diets containing
d-allethrin at 0, 125, 500, or 2000 mg/kg for 123 weeks. Reduced
body weight and increased liver and kidney weights were observed at
levels exceeding 500 mg/kg and the activities of glutamine-
oxaloacetic- and glutamine-pyruvic acid transaminase and alkaline
phosphatase decreased at these levels. Histopathological
examination showed histiocytes phagocyting crystals in the liver of
animals fed levels of 500 mg/kg or more, but no oncogenic effects
were observed at any dose level. The no-observed-adverse-effect
level was 125 mg/kg, i.e., 5.9 mg/kg body weight per day (male) and
6.6 mg/kg per day (female) (Sato et al., 1985).
6.6 Mutagenicity and Related End-Points
The mutagenic potential of allethrin has been examined in a
wide range of tests including in vitro/in vivo gene mutation, DNA
damage and repair, and in vitro/in vivo structural chromosomal
aberration (Suzuki, 1975; Miyamoto, 1976; Suzuki, 1979; Kawachi et
al., 1979; Kishida & Suzuki, 1979; Matsuoka et al., 1979; Hara &
Suzuki, 1980; Sasaki et al., 1980; Kimmel et al., 1982; Garret et
al., 1986). The results of all tests were negative with the
exception of a gene mutation Salmonella typhimurium study with
metabolic activation and a chromosomal aberration study on Chinese
hamster cells (Matsuoka, et al., 1979; Kimmel et al., 1982). Both
studies are considered inadequate because, in the gene mutation
study the results were found to be attributable to photoproducts in
improperly stored samples and, in the second study, the purity of
the test material was not identified (Isobe et al., 1982, 1984).
Bioallethrin and esbiothrin were also tested for mutagenicity
in both in vitro mammalian test systems, the micronucleus test
system, and microbial assays and found to be negative (Peyre et
al., 1979; Chantot & Vannier, 1984; Richold et al., 1984; Vannier &
Fournex, 1984).
6.7 Reproductive Effects, Embryotoxicity, and Teratogenicity
When allethrins were administered to ICR mice during gestation
to examine maternal and embryotoxic effects (Table 7), no
significant adverse effects, such as abortion or resorption of the
fetus or embryo, external or skeletal abnormalities of pups, or
abnormalities in growth and organ differentiation, were observed at
the doses tested (Miyamoto, 1976).
Table 7. Teratological studies on allethrins isomers
-------------------------------------------------------------------
Compound Animalsa Dose mg/kg Route Administration
body weight (days of gestation)
per day
-------------------------------------------------------------------
d-Allethrin mouse 15,50,150 oral 7-12
S-Bioallethrin mouse 10,30,100 oral 7-12
-------------------------------------------------------------------
a Includes breeding of naturally delivered offspring.
Allethrin in corn oil was administered daily, by oral
intubation, to pregnant albino rabbits from day 6 to day 18 of
gestation at levels of 0 mg/kg (controls - corn oil only), 215
mg/kg (low level), and 350 mg/kg (high level). There were no
indications of compound related effects among the test animals,
which were similar to the controls in appearance, behaviour, body
weight gain, and food consumption; necropsy findings were also
similar.
The number of implantation sites compared with the number of
ovarian corpora lutea observed was similar in the pregnant animals
in control, low-dose, and high-dose groups. The number and
placement of implantation sites, the resorption sites, the numbers
of live and dead fetuses, and the fetal weights and lengths were
also similar in the control and test animals. Fetal skeletal
evaluations did not reveal any compound-related abnormalities or
trends towards lesser or greater development in the test fetuses
compared with the controls. Pups, of low- and high-dose animals,
delivered naturally, were similar in appearance, external
morphology, and behaviour. No compound-related observations were
found during the post-delivery period (40 days) or at necropsy of
the pups (Weatherholtz, 1972).
Bioallethrin was administered orally to pregnant Sprague-
Dawley rats from day 6 to day 15 of gestation at levels of 50, 125,
or 195 mg/kg body weight per day (Knickerbocker & Thomas, 1979).
At 195 mg/kg, maternal mortality was increased, but there were no
effects on dam body weight or weight gain during gestation. The
compound did not have any effects on pregnancy, implantations,
number of live fetuses, number of dead fetuses, or number of
resorption sites per dam. Skeletal examination of fetuses revealed
a significant increase in the number of litters with rudimentary
14 ribs at 50, 125, and 195 mg/kg as well as missing sternebrae at
50 mg/kg. However, these abnormalities were generally variations
rather than malformations. No soft-tissue abnormalities were
ascribed to treatment.
S-Bioallethrin was administered to pregnant Wistar rats from
day 9 to day 14 of gestation at the following doses: 0.025, 0.05,
0.1, or 0.2 ml/kg body weight (Shinoda et al., 1975). The
mortality rate at the dose of 0.2 ml/kg was 55%; at 0.01 and 0.05
ml/kg, the mortality rates were 4 and 5%, respectively. There were
no differences between the control and treated groups in the
numbers of implantations and live fetuses, and the frequency of
fetal death. The weights of live fetuses and the placenta from the
group administered 0.2 ml/kg were lower than those of the control
group. Fetal and placental weights in the groups receiving 0.1,
0.05, or 0.025 ml/kg were almost the same as those in the control
group. External abnormalities consisted of a cleft palate in one
fetus and a decreased number of digits in 7 fetuses from the same
pregnant dam (0.2 ml/kg). Skeletal abnormalities included lumbar
transforming into thoracic vertebrae and insufficient ossification
of the 5th sternebra; they were frequently observed in all groups
but appeared to be dose-related. Some other abnormalities observed
in a small number of fetuses from the treated groups included
partial fusion of the cervical vertebrae or of vertebrae arches and
ribs in the same fetuses in the 0.2 ml/kg group. Because of their
low frequency, these abnormalities could not be attributed to
treatment. In conclusion, S-Bioallethrin did not seem to induce
any disorders in the fetuses of pregnant rats administered doses
equal to or lower than 0.1 ml/kg, although some variations were
observed at the 0.2 mg/kg level.
Shinoda et al. (1975) also administered S-Bioallethrin orally
at 0.05, 0.1, or 0.2 ml/kg to pregnant TVCS mice from day 7 to day
12 of gestation. The mortality rate at 0.2 ml/kg was 40% and
pregnancy was maintained in only one dam. Some toxic symptoms were
observed at 0.1 ml/kg, and the mortality rate was 7%. The numbers
of implantations and of viable fetuses, the sex ratio, placental
and fetal weights in groups treated with 0.1 or 0.05 ml/kg, did not
differ from those of the control group. External examination
revealed that 2 fetuses from the 0.1 ml/kg treated group had cleft
palates; one of them had hydrocephaly. These abnormalities could
not be attributed to treatment because of their very low incidence
and the presence in the control group of one fetus with an
abdominal hernia and one with a cleft palate. There were not any
skeletal abnormalities that could be related to treatment. In
conclusion, at the maximum tolerated doses of S-Bioallethrin of 0.1
ml/kg and 0.05 ml/kg, no lethal effects occurred in the embryos or
fetuses and no teratogenic effects were observed.
6.8 Potentiation
Potentiation of toxicity between bioallethrin and piperonyl
butoxide was studied by the intraperitoneal route in the rat
(Wallwork & Malone, 1969). The degree of potentiation between the
2 compounds was very low.
6.9 Mechanism of Toxicity - Mode of Action
The toxic effects of allethrin result from its action on the
nervous system. After intravenous injection with a lethal dose of
bioallethrin (4 mg/kg body weight), initial tremors were followed
by death within 20 min. Hyperexcitation and tremors usually
developed a few minutes after application (Verschoyle & Barnes,
1972; Carlton, 1977; Wouters & Van den Bercken, 1978; Verschoyle &
Aldridge, 1980; Lawrence & Casida, 1982). Signs of poisoning in
vertebrates, including mammals, are similar to those in insects
(see Appendix).
Signs of poisoning in insects generally include
hyperexcitation, tremors, and convulsions, followed later by
paralysis and death. Narahashi (1969, 1971) examined signs of
poisoning electrophysiologically using the giant axon of the
cockroach. Allethrin caused an increase in negative after-
potential, repetitive discharge (or repetitive firing) following
electrical stimulation, and a conduction block, presumably by
allethrin binding to sodium channels. Good correlations existed in
cockroaches between the signs induced by allethrin and effects on
the nervous system. Restless behaviour, without a loss of
coordination, was correlated with repetitive discharge of cercal
sensory neurons, whereas the onset of uncoordinated behaviour
coincided with the appearance of abnormal discharges, not only in
cercal sensory neurons but also in motor neurons and the central
nervous system (CNS) (Gammon, 1979). Temperature had a profound
effect on allethrin-induced repetitive discharges and its nerve-
blocking action. In the giant axon of the cockroach treated with
allethrin, repetitive discharges appeared at over 26.5 °C and
increased with rise in temperature. Conversely, allethrin blocked
the action potential of the squid and cockroach giant axons more
strongly at 8 °C than at 23 °C (Wang et al., 1972). The negative
temperature coefficient of the nerve-blocking action of allethrin
appears to be responsible for a greater killing effect on insects,
and is in sharp contrast with the positive temperature coefficient
discharges, which may be responsible for knock-down of repetitive
(Wang et al., 1972; Starkus & Narahashi, 1978). When the
temperature was reduced from 23 to 8 °C in the voltage clamp
analysis, the inhibition of the transient sodium conductance and
the shift of the sodium conductance curve along the potential axis
in the direction of hyperpolarization were both increased, causing
a greater blocking of action potential (Narahashi, 1976).
However, it has been reported that the peripheral nerves of the
rat and the frog were fairly insensitive to the blocking action of
allethrin, and it was tentatively suggested that the nerve
membranes of vertebrates were less susceptible to the neurotoxic
action of allethrin than those of invertebrates. Allethrin causes
a depolarizing after-potential following the action potential and
induces pronounced repetitive firing in myelinated nerve fibres and
in the sense organs of frogs. In the frog peripheral nervous
system, virtually no blocking effect of allethrin occurs, except at
very high concentrations (Van den Bercken et al., 1979).
The sodium channel gating model was proposed by Van den Bercken
& Vijverberg (1980). The state of the sodium channel is controlled
by 2 independent gates called the activation gate (or m-gate) and
the inactivation gate (or h-gate), both of which are dependent on
the membrane potential, but in opposite ways. The action of
allethrin has been thought to stabilize the m-gate in its open
position.
Pyrethroids were classified into 2 classes based on the signs
and symptoms produced by acutely-toxic doses in mammals (Verschoyle
& Aldridge, 1980; Lawrence & Casida, 1982) and on the
neurophysiological responses in cockroaches (Gammon et al., 1981).
Type I syndrome involves hyperactivity and tremor in both insects
and mammals. Type II syndrome involves hyperactivity,
incoordination, and convulsions in insects, and clonic seizures
with sinuous writhing (choreoathetosis) in mammals. Allethrin is
classified as a Type I compound.
Interactions of allethrin with the nicotinic acetylcholine
(ACh) receptor channel were studied in membranes from the Torpedo
electric organ (Abbassy et al., 1982). Allethrin did not inhibit
binding of [3H]-ACh to the receptor sites, but noncompetitively
inhibited binding of [3H] perhydrohistrionico-toxin ([3H]H12-HTX)
to the ionic channel sites in a dose-dependent manner. The
inhibition constant (Ki) of [3H]H12-HTX binding in the absence of
receptor agonists was 30 µmol/litre while, in the presence of
100 µmol carbamylcholine/litre, it was 4 µmol/litre. This
inhibitory effect of allethrin had a negative temperature
coefficient. The high affinity binding of allethrin to the channel
sites of the nicotinic ACh-receptor may be indicative of a
postsynaptic site of action for allethrin, in addition to the known
action on the sodium channel.
The mechanism of interaction of the 2 pyrethroids, allethrin
and fluvalinate, with the nicotinic acetylcholine (ACh) receptor
was investigated by means of their effects on the binding of
radioligands to the Torpedo electric organ receptor and tracer ion
flux. The data suggest that allethrin and fluvalinate bind to
sites on the nicotinic ACh-receptor that are quite distinct from
the receptor site and the ionic channel sites where noncompetitive
blockers (e.g., [3H]H12HTX) bind. Such pyrethroids may be binding
to sites that normally bind Ca2+ and induce receptor
desensitization. The data imply that modulation of the nicotinic
ACh-receptor in insect ganglia may be involved in the mode of
action of pyrethroids (Sherby et al., 1986).
7. EFFECTS ON MAN
No data were available to the Task Group on the effects of
allethrins on man. However, allethrins have been used for many
years and no toxic effects on human beings have been reported.
8. EVALUATION OF HUMAN HEALTH RISKS AND EFFECTS ON THE ENVIRONMENT
8.1 Evaluation of Human Health Risks
Allethrin, consisting of 8 stereo-isomers, is an effective
insecticide mainly used to control household insects.
d-Allethrin, bioallethrin, esbiothrin, and S-Bioallethrin are
also available as selected stereo-isomers or mixtures thereof. It
is anticipated that human exposure will be mainly through the
inhalation of mists from aerosol sprays and from other household
uses, such as the electric mat and mosquito coil. The air level
following conventional household aerosol spraying of allethrin is
not expected to exceed 0.5 mg/m3. Air levels of individual isomers
are expected to be lower under similar conditions of use.
Although the levels of allethrins in food have not been
determined, on the basis of current use patterns, it is unlikely
that such dietary exposure will be significant.
No data are available on occupational exposure to the
allethrins. In fact, though they have been used for many years, no
data have been reported on their toxicity for human beings. Thus,
extrapolation of data from experimental animals and in vitro
studies must be relied on.
The results of short-term studies on experimental animals
suggest that allethrins are weakly to moderately toxic (oral or
dermal LD50 values of 210 - 4290 mg/kg; inhalation LC50 value
of > 1500 mg/m3).
Allethrins induce mild primary eye and skin irritation in
rabbits, but no skin sensitization.
The short-term toxicities of S-Bioallethrin and d-allethrin
appear to be low, according to several inhalation studies (mosquito
coil and mat) on mice and rats at a range of dose levels (10, 20,
or 25 times normal concentration used).
The allethrins are not mutagenic in a variety of test systems
including gene mutations, DNA damage and repair, and chromosomal
effects.
d-Allethrin was not carcinogenic for rats fed diets containing
2000 mg/kg over 2 years.
Relatively high doses of allethrin, bioallethrin, or
S-Bioallethrin were neither embryotoxic nor teratogenic for
rabbits, rats, or mice. No adequate reproduction studies have been
reported.
At near lethal doses, allethrins are likely to cause
hyperactivity, tremors, and convulsions and have been classified as
Type I pyrethroids.
No-observed-adverse-effect levels were established for
bioallethrin in a 90-day rat study and a 6-month study on dogs
(1500 mg/kg diet, 200 mg/kg diet, respectively, corresponding to
135 mg/kg body weight and 6.1 - 7.2 mg/kg body weight,
respectively). In a 2-year study on rats, the no-observed-
adverse-effect level for dietary administration of allethrin was
125 mg/kg, i.e., 5.9 and 6.6 mg/kg body weight per day for male and
female rats, respectively.
8.2 Evaluation of Effects on the Environment
Allethrins are primarily used indoors, but no information is
available on levels in the environment. They are rapidly
decomposed when exposed to sunlight and at temperatures exceeding
400 °C, but vaporize with slow heating at 150 °C.
Allethrins are toxic for fish with LC50 values of 9 - 90
µg/litre, but less toxic for Daphnia and aquatic insect larvae
(150 - 50 000 µg/litre). Toxicity is low for birds (LD50 > 2000
mg/kg), but high for honey-bees (LD50 3 - 9 µg/bee).
9. CONCLUSIONS
General population: Under recommended conditions of use, the
exposure of the general population to allethrins is negligible and
is unlikely to present a hazard.
Occupational exposure: With reasonable work practices, hygiene
measures, and safety precautions, the use of allethrins is unlikely
to present a hazard to those occupationally exposed to them.
Environment: Under recommended conditions of use and application
rates, it is unlikely that allethrins or their degradation products
will attain significant levels in the environment. In spite of the
high toxicity of these compounds for fish and honey-bees, they are
only likely to cause a problem in the case of spillage or misuse.
10. RECOMMENDATIONS
- Over 25 years of use, no adverse effects have been reported to
arise from human exposure to allethrins, but it is still
necessary to continue observations on human exposure.
- To improve the overall assessment of the potential
reproductive effects and potential carcinogenic effects of the
allethrins, it is suggested that consideration should be given
to conducting an appropriate multigeneration study and another
carcinogenicity study on a second species.
- The label for the household use of allethrins should include
adequate instructions for use and storage and, where
appropriate, warning of flammability.
- Efforts should be made to obtain a more precise estimate of
the total global usage of allethrins.
11. PREVIOUS EVALUATIONS BY INTERNATIONAL BODIES
The Joint FAO/WHO Meeting on Pesticide Residues (JMPR)
discussed and evaluated allethrin in 1965 (FAO/WHO, 1965). It did
not establish an ADI for allethrin, because data from long-term
studies were not available.
The Pesticide Development and Safe Use Unit, Division of Vector
Biology and Control, WHO, classified the acute hazard to health for
technical allethrin as slight and for technical bioallethrin as
moderate (WHO, 1986).
REFERENCES
ABBASSY, M.A., ELDENFRAWI, M.E., & ELDENFRAWI, T. (1982) Allethrin
interactions with the nicotinic acetylcholine receptor channel.
Life Sci., 31: 1547-1552.
AMBROSE, A.M. & ROBBINS, D.J. (1951) Comparative toxicity of
pyrethrins and allethrin. Fed. Proc., 10: 276.
ANONYMOUS (1968) Official document of US Department of the
Interior (USDI), Washington, DC, Federation of the Water Pollution
Control Administration, US Department of the Interior, p. 234.
AUDEGOND, L., COLLAS, E., & GLOMOT, R. (1979a) Bioallethrin. Acute
oral toxicity study in the rat, Romainville, France, Roussel Uclaf,
26 pp (Report No. RU-BA-79.829/A) (Unpublished proprietary data).
AUDEGOND, L., COLLAS, E., & GLOMOT, R. (1979b) Esbiothrin. Acute
oral toxicity study in the rat, Romainville, France, Roussel Uclaf,
27 pp (Report No. RU-EBT-79.828/A) (Unpublished proprietary data).
AUDEGOND, L., COLLAS, E., & GLOMOT, R. (1979c) Esbiol. Acute oral
toxicity study in the rat, Romainville, France, Roussel Uclaf, 30
pp (Report No. RU-SB-79.830/A) (Unpublished proprietary data).
AUDEGOND, L., COLLAS, E., & FOURNEX, R. (1984a) Esbiothrin. Primary
dermal irritancy study in the male rabbit, Romainville, France,
Roussel Uclaf, 12 pp (Report No. RU-EBT-83315/A) (Unpublished
proprietary data).
AUDEGOND, L., COLLAS, E., & FOURNEX, R. (1984b) Esbiothrin. Primary
eye irritation study in the male rabbit, Romainville, France,
Roussel Uclaf, 16 pp (Report No. RU-EBT-83.316/A) (Unpublished
proprietary data).
BABA, N. & OHNO, M. (1972) Thermal behavior of allethrin at 150 °C
in atmospheric environment. Agric. biol. Chem., 36: 56-61.
BATTELLE (1982) Pesticide programme of research and market
planning. Part I. Insecticides, Geneva, Battelle Institute
(October 1982).
BULLIVALENT, M.J. & PATTENDEN, G. (1973) Photolysis of
bioallethrin. Tetrahedron Lett., 38: 3679-3680.
CARLTON, M. (1977) Some effects of cismethrin on the rabbit nervous
system. Pestic. Sci., 8: 700-712.
CARPENTER, C.P., WEIL, C.S., POZZANI, U.C., & SMYTH, J.F., Jr
(1950) Comparative acute and subacute toxicities of allethrin and
pyrethrins. Arch. ind. Hyg., 2: 420-432.
CHANTOT, J.F. & VANNIER, B. (1984) Esbiothrin. Detection of a
mutagenic potency with a bacterial test (Ames test), Romainville,
France, Roussel Uclaf, 14 pp (Report No. RU-EBT-84.04/A)
(Unpublished proprietary data).
CHEN, Y.L. & CASIDA, J.E. (1969) Photodecomposition of pyrethrin I,
allethrin, phthalthrin and dimethrin. Modification in the acid
moiety. J. agric. food Chem., 17: 208-215.
CHESHER, B.C. & MALONE, J.C. (1972a) Bioallethrin. 24 hour exposure
rat inhalation study, Berkhamsted, United Kingdom, Wellcome
Foundation Ltd, 42 pp (Report No. WELL-BA-72.23.03/A) (Unpublished
proprietary data supplied by Roussel Uclaf).
CHESHER, B.C. & MALONE, J.C. (1972b) Bioallethrin. 10 consecutive
days rat inhalation, Berkhamsted, United Kingdom, Wellcome
Foundation Ltd, 41 pp (Report No. WELL-BA-72.28.03/A) (Unpublished
proprietary data supplied by Roussel Uclaf).
COPE, O.B. (1965) Sport fishery investigation, in the effects of
pesticides on fish and wildlife. US Fish Wildl. Serv. Circ.,
226: 51-64.
DESMARCHELIER, J.M. (1976) Analysis of pyrethroids on grains.
J. stored Prod. Res., 12: 245-252.
DEVAUX, Ph. & BOLLA, P. (1986a) Bioallethrin. Water solubility,
Romainville, France, Roussel Uclaf, 5 pp (Report No. STE-BA-
057.07.1/A) (Unpublished proprietary data).
DEVAUX, Ph. & BOLLA, P. (1986b) Bioallethrin. n-octanol/water
partition coefficient, Romainville, France, Roussel Uclaf, 4 pp
(Report No. STE-BA-057.C.06.1/A) (Unpublished proprietary data).
DEVAUX, Ph. & TILLIER, C. (1986) Vapour pressure of bioallethrin
and bioresmethrin, Romainville, France, Roussel Uclaf, 8 pp (Report
No. RU-BRM/BA-150.06.86.STE/A) (Unpublished proprietary data).
ELLIOTT, M. (1977) Synthetic pyrethroids, Washington, DC, American
Chemical Society, 229 pp (ACS Symposium Series No. 42).
ELLIOTT, M., JANES, N.F., CASIDA, J.E., & KIMMEL, E.C. (1972a)
Mammalian metabolites of pyrethroids. Pyrethrum Post, 11: 94-103.
ELLIOTT, M., JANES, N.F., KIMMEL, E.C., & CASIDA, J.E. (1972b)
Metabolic fate of pyrethrin I, pyrethrin II and allethrin
administered orally to rats. J. agric. food Chem., 20: 300-313.
EVANS, M.H. (1976) End-plate potentials in frog muscle exposed to a
synthetic pyrethroid. Pestic. Biochem. Physiol., 6: 547-550.
FAO (1982) Second Government Consultation on International
Harmonization of Pesticide Registration Requirements, Rome, 11-15
October, 1982, Rome, Food and Agriculture Organization of the
United Nations.
FAO/WHO (1965) Allethrin. In: Evaluation of the toxicity of
pesticide residues in food, Rome, Food and Agriculture Organization
of the United Nations, pp. 20-23 (FAO Meeting Report No.
PL/1965/10/1 - WHO Food Add./27.65).
FISCH, H. (1974) Primary irritation evaluation program study,
Springfield, National Technical Information Service, p. 4 (NTIS
Report No. 51-029-75).
FLANNIGAN, S.A. & TUCKER, S.B. (1985) Variation in cutaneous
sensation between synthetic pyrethroid insecticides. Contact
Dermatitis, 13: 140-147.
GAMMON, D.W. (1979) An analysis of the temperature-dependence of
the toxicity of allethrin to the cockroach. In: Narahashi, T., ed.
Neurotoxicology of insecticides and pheromones, New York, Plenum
Press, pp. 97-117.
GAMMON, D.W. & CASIDA, J.E. (1983) Pyrethroids of the most potent
class antagonize GABA action at the crayfish neuromuscular
junction. Neurosci. Lett., 40: 163-168.
GAMMON, D.W., BROWN, M.A., & CASIDA, J.E. (1981) Two classes of
pyrethroid action in the cockroach. Pestic. Biochem. Physiol.,
15: 181-191.
GAMMON, D.W., LAWRENCE, L.J., & CASIDA, J.E. (1982) Pyrethroids
toxicology: Protective effects of Diazepam and phenobarbital in the
mouse and the cockroach. Toxicol. appl. Pharmacol., 66: 290-296.
GARRET, N.E., FRANK STACK, H., & WATERS, M.D. (1986) Evaluation of
the genetic activity profiles of 65 pesticides. Mutat. Res.,
168: 301-325.
GLICKMAN, A.H. & CASIDA, J.E. (1982) Species and structural
variations affecting pyrethroid neurotoxicity. Neurobehav. Toxicol.
Teratol., 4: 793-799.
GRIGGS, M.P., JEFFERSON, N.D., BLAIR, M., & SPICER, E.J.F. (1982)
Bioallethrin. 6-month dietary toxicity study in dogs, IRDC
Mattawan, Michigan, 69 pp (Report No. IRDC-BA-406.034/A)
(Unpublished proprietary data supplied by Roussel Uclaf).
HARA, M. & SUZUKI, H. (1980) In vivo chromosomal aberration test of
allethrin on mouse bone marrow cells, Takarazuka, Sumitomo Chemical
Co., Ltd (Report No. KT-00-0056) (Unpublished proprietary data).
HARDY, C.J., JACKSON, G.C., LEWIS, D.J., & GOPINATH, C. (1984)
Esbiothrin (RU 27436). Acute inhalation toxicity in rats 4-hour
exposure, Huntingdon, United Kingdom, Huntingdon Research Centre,
118 pp (Report No. RSL-EBT-84.470/A) (Unpublished proprietary data
supplied by Roussel Uclaf).
ISOBE, N., MIHARA, K., SUZUKI, H., MATSUO, M., & MIYAMOTO, J.
(1982) Identification of a mutagen in photooxidation products of
allethrin, Takarazuka, Research Department, Pesticide Division,
Sumitomo Chemical Co., Ltd (Technical Report No. 57-7-28)
(Proprietary data made available by Sumitomo Chemical Co., Ltd).
ISOBE, N., MATSUO, M., & MIYAMOTO, J. (1984) Nevel photo-products
of allethrin. Tetrahedron Lett., 25: 861-864.
JAPAN PLANT PROTECTION ASSOCIATION (1984) [Pesticide manual]
(Noyaku Yoran), Tokyo, Japan Plant Protection Association, p. 5
(in Japanese).
KADOTA, T. (1972) 90-day subacute toxicity study of Pynamin Forte
on rats, Takarazuka, Research Department, Pesticide Division,
Sumitomo Chemical Co., Ltd (Technical Report No. KT-70-0006)
(Proprietary data made available by Sumitomo Chemical Co., Ltd).
KADOTA, T., KOHDA, H., & MIYAMOTO, J. (1974) Subacute inhalation
toxicity study of mosquito coils containing 0.3% Pynamin Forte in
mice and rats, Hyogo, Research Department, Pesticide Division,
Sumitomo Chemical Co., Ltd (Technical Report No. KT-40-0031).
KAWACHI, T., YAHAGI, T., KADA, T., TAZIMA, Y., ISHIDATE, M.,
SASAKI, M., & SUGIYAMA, T. (1979) Cooperative programme on short-
term assays for carcinogenicity in Japan. In: Montesano, R.,
Bartsch, H., & Tomatis, L., ed. Molecular and cellular aspects of
carcinogen screening tests, Lyons, International Agency for
Research on Cancer, pp. 323-330 (IARC Scientific Publications No.
27).
KAWANO, Y., YANAGIHARA, K., MIYAMOTO, T., & YAMAMOTO, I. (1980)
Examination of the conversion products of pyrethrins and allethrin
formulations exposed to sunlight by gas chromatography and mass
spectroscopy. J. Chromatogr., 198: 317-328.
KAYSEN, A. & SALES, A. (1984) Esbiothrin. Acute dermal toxicity in
male and female rabbits, Evreux, France, Centre International de
Toxicologie, 36 pp (Report No. CIT-EBT-430.84/A) (Unpublished
proprietary data supplied by Roussel Uclaf)
KIMMEL, E.C., CASIDA, J.E., & RUZO, L.O. (1982) Identification of
mutagenic photoproducts of pyrethroids allethrin and terallethrin.
J. agric. food Chem., 30: 623-626.
KISHIDA, F. & SUZUKI, H. (1979) Mutagenicity test of allethrin in
bacterial test systems, Takarazuka, Research Department, Pesticide
Division, Sumitomo Chemical Co., Ltd (Technical Report No. KT-90-
0054) (Unpublished proprietary data made available by Sumitomo
Chemical Co., Ltd).
KNICKERBOCKER, M. & THOMAS, A.R. (1979) Teratological evaluation
of d-trans allethrin in Sprague-Dawley rats, USA, FDRL, 37 pp
(Report No. FDRL-BA-79.20.04/A) (Unpublished proprietary data
supplied by Roussel Uclaf).
KYOGOKU, K., IGUCHI, T., YAMAGUCHI, H., & MURAYAMA, H. (1970)
Studies of pyrethroid insecticides. Part IV. Pyrolysis gas
chromatography of allethrin, phthalthrin and other chrysanthemic
acid esters. Nippon Nogeikagaku Kaishi, 44: 532-537.
LAWRENCE, L.J. & CASIDA, J.E. (1982) Pyrethroid toxicology: Mouse
intracerebral structure-toxicity relationship. Pestic. Biochem.
Physiol., 18: 9-14.
LAWRENCE, L.J. & CASIDA, J.E. (1983) Stereospecific action of
pyrethroid insecticides on the gamma-aminobutyric acid receptor-
ionophore complex. Science, 221: 1399-1401.
LAWRENCE, L.J., GEE, K.W., & YAMAMURA, H.I. (1985) Interactions of
pyrethroid insecticides with chloride ionophore-associated binding
sites. Neurotoxicology, 6: 87-98.
LEAHEY, J.P. (1985) The pyrethroid insecticides, London, Taylor &
Francis, 440 pp.
LEHMAN, A.J. (1952) Summaries of pesticide toxicity, Q. Bull.
Assoc. Food Drug Off., 16: 47.
LEHMAN, A.J. (1965) Summaries of pesticide toxicity, Topeca,
Kansas, US Association of Food and Drug Officers.
LUND, A.E. & NARAHASHI, T. (1983) Kinetics of sodium channel
modification as the basis for the variation in the serve membrane
effects of pyrethroids and DDT analogs. Pestic. Biochem. Physiol.,
20: 203-216.
MCCLELLAN, D.B. & MOORE, J.B. (1958) Determination of allethrin
residues in milk and meats. J. agric. food Chem., 6: 463-465.
MARTIN, H. & WORTHING, C.R. (1977) The pesticide manual, 5th ed.,
Croydon, British Crop Protection Council, p. 7.
MATSUOKA, A., HAYASHI, M., & ISHIDATE, M. (1979) Chromosomal
aberration test on 29 chemicals combined with S9 mix in vitro.
Mutat. Res., 66: 277-290.
MAUCK, W.L., OLSON, L.E., & MARKING, L.L. (1976) Toxicity of
natural pyrethroids and five pyrethroids to fish. Arch. environ.
Contam. Toxicol., 4: 18-29.
MEISTER, R.T., BERG, G.L., SINE, C., MEISTER, S., & POPLYK, J.
(1983) Farm chemicals handbook. Section C. Pesticide dictionary,
Willoughby, Meister Publishing Co., pp. C10-C11.
MIYAMOTO, J. (1976) Degradation and metabolism and toxicity of
synthetic pyrethroids. Environ. Health Perspect., 14: 15-28.
MIYAMOTO, J. (1981) The chemistry, metabolism and residue analysis
of synthetic pyrethroids. Pure appl. Chem., 53: 1967-2022.
MIYAMOTO, J. & KEARNEY, P.C. (1983) Pesticide chemistry-human
welfare and the environment. Proceedings of the Fifth International
Congress of Pesticide Chemistry, Kyoto, Japan, 29 August-4
September, 1982, Oxford, Pergamon Press (in 4 volumes).
MOTOYAMA, I., YANAGIDAIRA, T., SAKAI, A., MINAKAMI, T., & TAGUCHI,
H. (1975a) Esbiol. The results of subacute and chronic toxicity
tests in the rat (6-month study), Shinshu, Japan, Shinshu
University Medical College, 54 pp (Report No. SU-SB-75.07.19/A)
(Unpublished proprietary data supplied by Roussel Uclaf).
MOTOYAMA, I., YANAGIDAIRA, T., SAKAI, A., & MINAKAMI, T. (1975b)
Esbiol. Skin irritant tests in rabbits and rats, Shinshu, Japan,
Shinshu University Medical College, 4 pp (Report No. SV-SB-
75.07.24/A) (Unpublished proprietary data supplied by Roussel
Uclaf).
MURANO, A. (1972) Determination of the optical isomers of
insecticidal pyrethroids by gas-liquid chromatography. Agric. biol.
Chem., 36: 2203-2211.
NAKADA, Y., YURA, Y., & MURAYAMA, K. (1971) Pyrolysis of allethrin.
Bull. Chem. Soc. Jpn, 44: 1724.
NAKANISHI, M., MUKAI, T., TAKEUCHI, M., & EDANAGA, M. (1970)
Toxicological studies on a new pyrethroid: Kikuthrin. Part I.
Studies on insecticide V. Botyu-Kagaku, 35: 103-112.
NARAHASHI, T. (1969) Mode of action of DDT and allethrin on nerve:
cellular and molecular mechanisms. Residue Rev., 25: 275-288.
NARAHASHI, T. (1971) Mode of action of pyrethroids. Bull. World
Health Organ., 44: 337-345.
NARAHASHI, T. (1976) Nerve membrane as a target of pyrethroids.
Pestic. Sci., 7: 267-272.
NIOSH (1983) In: Tatken, R.L. & Lewis, R.J., Jr, ed. Registry of
toxic effects of chemical substances, 1981-82 edition, Cincinnati,
Ohio, National Institute for Occupational Safety and Health,
3057 pp.
NISHIUCHI, Y. (1981) Toxicity of pesticides to some aquatic
organisms. I. Toxicity of pesticides to some aquatic insects.
Seitai-kagaku, 4: 31-46.
OGAMI, H., SHIMADA, T., & KAMITAMARI, M. (1975) Esbiol mosquito
coils acute inhalation toxicity tests in the mouse and rat, Japan,
Japan Mosquito Coil Co., Ltd, 9 pp (Report No. BRD-SB-75-02.25/A)
(Unpublished proprietary data supplied by Roussel Uclaf).
PEYRE, M., CHANTOT, J.F., PENASSE, L., VANNIER, B., & GLOMOT, R.
(1979) Detection of a mutagenic potency of bioallethrin 1/
Microbial assays (2) Micronucleus test in the mouse, Romainville,
France, Roussel Uclaf, 36 pp (Unpublished proprietary data).
RICHOLD, M., EDGAR, D.H., RANSOME, S.J., BANKS, S.J., & BOSWORTH,
H.J. (1984) An assessment of the mutagenic potential of esbiothrin
using an in vitro mammalian cell test system, Huntingdon, United
Kingdom, Huntingdon Research Centre, 37 pp (Report No. RSL-EBT-
642/84422/A) (Unpublished proprietary data supplied by Roussel
Uclaf).
RUIGT, G.S.F. & VAN DEN BERCKEN, J. (1986) Action of pyrethroids on
a nerve-muscle preparation of the clawed frog, Xenopus laevis.
Pestic. Biochem. Physiol., 25: 176-187.
RUZO, L.O., GAUGHAN, L.C., & CASIDA, J.E. (1980) Pyrethroid
photochemistry: S-Bioallethrin. J. agric. food Chem., 28: 246-249.
SAKAMOTO, Y., MATSUMOTO, K., & OGAMI, H. (1975a) Irritant effect of
esbiol and allethrin on the eye mucosa of the rabbit, Osaka, Japan,
Osaka University Medical School, 4 pp (Report No. OU-SB-75.03.22/A)
(Unpublished proprietary data supplied by Roussel Uclaf).
SAKAMOTO, Y., MATSUMOTO, K., & OGAMI, H. (1975b) Esbiol mosquito
coils subacute inhalation toxicity tests in the mouse and rat,
Osaka, Japan, Osaka University Medical School, 44 pp (Report No.
OU-SB-75.06.07/A) (Unpublished proprietary data supplied by Roussel
Uclaf).
SAKAMOTO, Y., MATSUMOTO, K., OGAMI, H., YOSHIMURA, M., SHINADA, T.,
& KAMITAMARI, M. (1975c) Esbiol acute inhalation toxicity tests in
the mouse and rat, Osaka, Japan, Osaka University Medical School,
15 pp (Report No. OU-SB-75.02.15/A) (Unpublished proprietary data
supplied by Roussel Uclaf).
SAKAMOTO, Y., MATSUMOTO, K., OGAMI, H., YOSHIMURA, M., SANO, N., &
SHIMADA, T. (1975d) Esbiol subacute inhalation toxicity tests in
the mouse and rat (one-month), Osaka, Japan, Osaka University
Medical School, 52 pp (Report No. OU-SB-75.05.27/A) (Unpublished
proprietary data supplied by Roussel Uclaf).
SAKAUE, S., DOI, T., & DOI, T. (1985) Determination of allethrin
and other pesticides in mosquito coils by the shaking extraction
method. Agric. biol. Chem., 49(4): 921-924.
SANDERS, H.J. & TAFF, A.W. (1954) Allethrin. Ind. eng. Chem.,
46: 414-426.
SANDERS, H.O. (1969) Toxicity of pesticides to the crustaneans,
Gammarus lacustris, Washington, DC, US Department of the Interior,
Bureau of Sport Fishery and Wildlife, p. 18 (Technical Paper No.
25).
SANDERS, H.O. & COPE, O.B. (1966) Toxicities of several pesticides
to two species of Cladocerans. Trans. Am. Fish. Soc., 95: 165-169.
SANDERS, H.O. & COPE, O.B. (1968) The relative toxicities of
several pesticides to naiads of three species of stoneflies.
Limnol. Oceanogr., 13: 112-117.
SASAKI, M., SUGIMURA, K., YOSHIDA, A., & ABE, S. (1980) Cytogenetic
effects of 60 chemicals on cultured human and Chinese hamster
cells. Kromosomo II, 20: 574-584.
SATO, H., ARAI, M., HAGIWARA, A., & ARAI, M. (1985) Chronic
toxicity and oncogenicity study of Pynamin Forte in rats, Nagoya,
Japan, Daiyu-kai Institute of Medical Sciences (Technical Report
No. KT-51-0058) (Proprietary data made available by Sumitomo
Chemical Co., Ltd).
SAUNDERS, J.L. & VERCOE, R.R. (1970) Sensitization study with
bioallethrin on guinea pigs, Berkhamsted, United Kingdom, Wellcome
Foundation Ltd, 4 pp (Report No. WELL-BA-70.23.02/A) (Unpublished
proprietary data supplied by Roussel Uclaf).
SCHECHTER, M.S., GREEN, N., & LAFORGE, F.B. (1949) Constituents of
pyrethrum flowers XXIII. Cinerolone and synthesis of related
cyclopentenolones. J. Am. Chem. Soc., 71: 3165-3173.
SHERBY, S.M., ELDEFRAWI, A.T., DESHPANDE, S.S., ALBUQUERQUE, E.X.,
& ELDEFRAWI, M.E. (1986) Effects of pyrethroids on nicotinic
acetylcholine receptor binding and function. Pestic. Biochem.
Physiol., 26: 107-115.
SHINODA, N., SUGIYAMA, O., & TAKAGAKI, Y. (1975) Esbiol
teratological test results in rats and mice, Japan, Chugai
Pharmaceutical Co., Ltd, 42 pp (Report No. CP-SB-75.02.28.A)
(Unpublished proprietary data supplied by Roussel Uclaf).
STARKUS, J.G. & NARAHASHI, T. (1978) Temperature dependence of
allethrin-induced repetitive discharges in nerves. Pestic. Biochem.
Physiol., 9: 225-230.
STEVENSON, J.H., NEEDHAM, P.H., & WALKER, J. (1978) Poisoning of
honey-bee by pesticides: Investigations of the changing pattern in
Britain over 20 years, Rothamsted, United Kingdom, Rothamsted
Experimental Station, Part 2, pp. 55-72.
SUZUKI, H. (1975) Mutagenicity of some synthetic pyrethroids in
bacterial test systems, Takarazuka, Sumitomo Chemical Co., Ltd
(Report No. KT-50-0026) (Unpublished proprietary information made
available by Sumitomo Chemical Co., Ltd).
SUZUKI, H. (1979) In vitro sister chromatid exchange test of
allethrin, Takarazuka, Sumitomo Chemical Co., Ltd (Report No.
KT-90-0055) (Unpublished proprietary information made available by
Sumitomo Chemical Co., Ltd).
TSUCHIYAMA, H., SUGIHARA, S., KAWAI, K., ITOH, M., MEGURO, H.,
HARA, N., & KUBO, T. (1975) Electric mosquito mat, subacute
inhalation toxicity tests in mice, Nagasaki, Japan, Nagasaki
University Medical School, 77 pp (Report No. NU-SB-75.08.24/A)
(Unpublished proprietary data supplied by Roussel Uclaf).
TUCKER, R.K. & CRABTREE, D.G. (1970) Handbook of toxicity of
pesticides to wildlife, Washington, DC, US Department of the
Interior, Bureau of Sport Fishery and Wildlife, 131 pp (Resource
Publication No. 84131).
UNO, M., OKADA, T., OHMAE, T., TERADA, I., & TANIGAWA, K. (1982)
[Determination of pyrethroid insecticides by dual-wavelength
densitometry.] Shokuhin Eiseigaku Zasshi, 23: 191-195
(in Japanese).
VAN DEN BERCKEN, J. (1977) The action of allethrin on the
peripheral nervous system of the frog. Pestic. Sci., 8: 692-699.
VAN DEN BERCKEN, J. & VIJVERBERG, H.P.M. (1980) Voltage clamp
studies on the effects of allethrin and DDT on the sodium channels
in frog myelinated nerve membrane. In: Insect neurobiology and
pesticide action (Neutox 79)2, London, Society of Chemical
Industry, pp. 78-85.
VAN DEN BERCKEN, J., AKKERMANS, L.M.A., & VAN DER ZALM, J.M. (1973)
DDT-like action of allethrin in the sensory nervous system of
Xenopus laevis. Eur. J. Pharmacol., 21: 95-106.
VAN DEN BERCKEN, J., KROESE, A.B.A., & AKKERMANS, L.M.A. (1979)
Effects of insecticides on the sensory nervous system. In:
Narahashi, T., ed. Neurotoxicology of insecticides and pheromones,
New York, Plenum Press, pp. 183-210.
VANNIER, B. & FOURNEX, R. (1984) Esbiothrin. Detection of mutagenic
potency (micronucleus test in the mouse), Romainville, France,
Roussel Uclaf, 14 pp (Report No. RU-EBT-84.603/A) (Unpublished
proprietary data).
VERCOE, R.R. & MALONE, J.C. (1969) Dermal irritancy of pyrethroids
and piperonyl butoxide to rabbits, Berkhamsted, United Kingdom,
Wellcome Foundation Ltd, 5 pp (Report No. WELL-BA-69.19.03/A)
(Unpublished proprietary data supplied by Roussel Uclaf).
VERSCHOYLE, R.D. & ALDRIDGE, W.N. (1980) Structure-activity
relationship of some pyrethroids in rats. Arch. Toxicol.,
45: 325-329.
VERSCHOYLE, R.D. & BARNES, J.M. (1972) Toxicity of natural and
synthetic pyrethrins to rats. Pestic. Biochem. Physiol.,
2: 308-311.
VIJVERBERG, H.P.M. & VAN DEN BERCKEN, J. (1979) Frequency dependent
effects of the pyrethroid insecticide decamethrin in frog
myelinated nerve fibres. Eur. J. Pharmacol., 58: 501-504.
VIJVERBERG, H.P.M. & VAN DEN BERCKEN, J. (1982) Action of
pyrethroid insecticides on the vertebrate nervous system.
Neuropathol. appl. Neurobiol., 8: 421-440.
VIJVERBERG, H.P.M., RUIGT, G.S.F., & VAN DEN BERCKEN, J. (1982a)
Structure-related effects of pyrethroid insecticides on the
lateral-line sense organ and on peripheral nerves of the clawed
frog, Xenopus laevis. Pestic. Biochem. Physiol., 18: 315-324.
VIJVERBERG, H.P.M., VAN DER ZALM, J.M., & VAN DEN BERCKEN, J.
(1982b) Similar mode of action of pyrethroids and DDT on sodium
channel gating in myelinated nerves. Nature (Lond.), 295: 601-603.
VIJVERBERG, H.P.M., VAN DER ZALM, J.M., VAN KLEEF, R.G.D.M., & VAN
DEN BERCKEN, J. (1983) Temperature- and structure-dependent
interaction of pyrethroids with the sodium channel in frog node of
Ranvier. Biochem. Biophys. Acta, 728: 73-82.
WALLWORK, L. & MALONE, J.C. (1969) Potentiation studies between
bioallethrin and piperonyl butoxide, Berkhamsted, United Kingdom,
Wellcome Foundation Ltd, 3 pp (Report No. WELL-BA-69.30.12/A)
(Unpublished proprietary data supplied by Roussel Uclaf).
WALLWORK, L., CLAMPITT, R.B., & MALONE, J.C. (1972) Bioallethrin
rat oral 90-day toxicity study, Berkhamsted, United Kingdom,
Wellcome Foundation Ltd, 77 pp (Report No. WELL-BA- 75.16-02/A)
(Unpublished proprietary data supplied by Roussel Uclaf).
WANG, C.M., NARAHASHI, T., & SCUKA, M. (1972) Mechanism of negative
temperature coefficient of nerve-blocking action of allethrin.
J. Pharmacol. exp. Ther., 182: 442-453.
WEATHERHOLTZ, W.M. (1972) Teratology study of Pynamin in rabbits.
Final report, Vienna, Virginia, Hazleton Laboratory Inc. (Project
No. 343-109) (Proprietary data made available by Sumitomo Chemical
Co., Ltd).
WHO (1979) WHO Technical Report Series, No. 634 ( Safe use of
pesticides. Third Report of the WHO Expert Committee on Vector
Biology and Control), pp. 18-24.
WHO (1986) The WHO recommended classification of pesticides by
hazard and guidelines to classification 1986-87, Geneva, World
Health Organization, p. 38 (VBC/86.1, Rev. 1).
WING, K.D. & HAMMOCK B.D. (1979) Stereoselectivity of a
radioimmunoassay for the insecticide S-Bioallethrin. Experientia
(Basel), 35: 1619-1620.
WORTHING, C.R. & WALKER, S.B. (1983) The pesticide manual, 7th ed.,
Croydon, British Crop Protection Council, p. 7.
WOUTERS, W. & VAN DEN BERCKEN, J. (1978) Action of pyrethroids.
Gen. Pharmacol., 9: 387-398.
YAMAMOTO, I. (1970) Mode of action of pyrethroids, nicotinoids,
and rotenoids. Annu. Rev. Entomol., 15: 257-272.
YAMAMOTO, I., UNAI, T., SUZUKI, Y., & KATSUDA, Y. (1976)
Preparation, stabilization, and insecticidal activity of
cyclodextrin-inclusion compounds of pyrethroids. J. Pestic. Sci.,
1: 41-48.
YOSHIOKA, H. (1980) [Chemistry and action of the recent synthetic
pyrethroids and their stereoisomers.] J. synth. org. Chem. Jpn,
38: 1151-1162 (in Japanese).
ZITKO, V., CARSON, W.G., & METCALF, C.D. (1977) Toxicity of
pyrethroids to juvenile atlantic salmon. Bull. environ. Contam.
Toxicol., 18: 35-41.
APPENDIX
On the basis of electrophysiological studies with peripheral
nerve preparations of frogs (Xenopus laevis; Rana temporaria, and
Rana esculenta), it is possible to distinguish between 2 classes of
pyrethroid insecticides: (Type I and Type II). A similar
distinction between these 2 classes of pyrethroids has been made on
the basis of the symptoms of toxicity in mammals and insects (Van
den Bercken et al., 1979; WHO, 1979; Verschoyle & Aldridge, 1980;
Glickman & Casida, 1982; Lawrence & Casida, 1982). The same
distinction was found in studies on cockroaches by Gammon et al.
(1981).
Based on the binding assay on the gamma-aminobutyric acid
(GABA) receptor-ionophore complex, synthetic pyrethroids can also
be classified into two types: the alpha-cyano-3-phenoxy-benzyl
pyrethroids and the non-cyano pyrethroids (Gammon et al., 1982;
Gammon & Casida, 1983; Lawrence & Casida, 1983; Lawrence et al.,
1985).
Pyrethroids that do not contain an alpha-cyano group (allethrin,
d-phenothrin, permethrin, tetramethrin, cismethrin, and
bioresmethrin) (Type I: T-syndrome)
The pyrethroids that do not contain an alpha-cyano group give
rise to pronounced repetitive activity in sense organs and in
sensory nerve fibres (Van den Bercken et al., 1973). At room
temperature, this repetitive activity usually consists of trains of
3 - 10 impulses and occasionally up to 25 impulses. Train duration
is between 10 and 5 milliseconds.
These compounds also induce pronounced repetitive firing of the
presynaptic motor nerve terminal in the neuromuscular junction (Van
den Bercken, 1977). There was no significant effect of the
insecticide on neurotransmitter release or on the sensitivity of
the subsynaptic membrane or the muscle fibre membrane. Presynaptic
repetitive firing was also observed in the sympathetic ganglion
treated with these pyrethroids.
In the lateral-line sense organ and in the motor nerve
terminal, but not in the cutaneous touch receptor or in sensory
nerve fibres, the pyrethroid-induced repetitive activity increases
dramatically as the temperature is lowered, and a decrease of 5 °C
in temperature may cause a more than 3-fold increase in the number
of repetitive impulses per train. This effect is easily reversed
by raising the temperature. The origin of this "negative
temperature coefficient" is not clear (Vijverberg et al., 1983).
Synthetic pyrethroids act directly on the axon through
interference with the sodium channel gating mechanism that
underlies the generation and conduction of each nerve impulse.
The transitional state of the sodium channel is controlled by 2
separately acting gating mechanisms, referred to as the activation
gate and the inactivation gate. Since pyrethroids only appear to
affect the sodium current during depolarization, the rapid opening
of the activation gate and the slow closing of the inactivation
gate proceed normally. However, once the sodium channel is open,
the activation gate is restrained in the open position by the
pyrethroid molecule. While all pyrethroids have essentially the
same basic mechanism of action, the rate of relaxation differs
substantially for the various pyrethroids (Flannigan & Tucker,
1985).
In the isolated node of Ranvier, allethrin causes prolongation
of the transient increase in sodium permeability of the nerve
membrane during excitation (Van den Bercken & Vijverberg, 1980).
Evidence so far available indicates that allethrin selectively
slows down the closing of the activation gate of a fraction of the
sodium channels that open during depolarization of the membrane.
The time constant of closing of the activation gate in the
allethrin-affected channels is about 100 milliseconds compared with
less than 100 microseconds in the normal sodium channel, i.e., it
is slowed down by a factor of more than 100. This results in a
marked prolongation of the sodium current across the nerve membrane
during excitation, and this prolonged sodium current is directly
responsible for the repetitive activity induced by allethrin
(Vijverberg et al., 1983).
The effects of cismethrin on synaptic transmission in the frog
neuromuscular junction, as reported by Evans (1976), are almost
identical to those of allethrin, i.e., presynaptic repetitive
firing, and no significant effects on transmitter release or on the
subsynaptic membrane.
Interestingly, the action of these pyrethroids closely
resembles that of the insecticide DDT in the peripheral nervous
system of the frog. DDT also causes pronounced repetitive activity
in sense organs, in sensory nerve fibres, and in motor nerve
terminals, due to a prolongation of the transient increase in
sodium permeability of the nerve membrane during excitation.
Recently, it was demonstrated that allethrin and DDT have
essentially the same effect on sodium channels in frog myelinated
nerve membrane. Both compounds slow down the rate of closing of a
fraction of the sodium channels that open on depolarization of the
membrane (Van den Bercken et al., 1973, 1979; Vijverberg et al.,
1982b).
In the electrophysiological experiments using giant axons of
crayfish, the Type I pyrethroids and DDT analogues retain sodium
channels in a modified open state only intermittantly, cause large
depolarizing after-potentials, and evoke repetitive firing with
minimal effect on the resting potential (Lund & Narahashi, 1983).
These results strongly suggest that permethrin and cismethrin,
like allethrin, primarily affect the sodium channels in the nerve
membrane and cause a prolongation of the transient increase in
sodium permeability of the membrane during excitation.
The effects of pyrethroids on end-plate and muscle action
potentials were studied in the pectoralis nerve-muscle preparation
of the clawed frog (Xenopus laevis). Type I pyrethroids
(allethrin, cismethrin, bioresmethrin, and 1R, cis-phenothrin)
caused moderate presynaptic repetitive activity, resulting in the
occurrence of multiple end-plate potentials (Ruigt & Van den
Bercken, 1986).
Pyrethroids with an alpha-cyano group on the 3-phenoxybenzyl
alcohol (deltamethrin, cypermethrin, fenvalerate, and fenpropanate)
(Type II: CS-syndrome)
The pyrethroids with an alpha-cyano group cause an intense
repetitive activity in the lateral-line organ in the form of long-
lasting trains of impulses (Vijverberg et al., 1982a). Such a
train may last for up to 1 min and contains thousands of impulses.
The duration of the trains and the number of impulses per train
increase markedly on lowering the temperature. Cypermethrin does
not cause repetitive activity in myelinated nerve fibres. Instead,
this pyrethroid causes a frequency-dependent depression of the
nervous impulse, brought about by a progressive depolarization of
the nerve membrane as a result of the summation of depolarizing
after-potentials during train stimulation (Vijverberg & Van den
Bercken, 1979; Vijverberg et al., 1983).
In the isolated node of Ranvier, cypermethrin, like allethrin,
specifically affects the sodium channels of the nerve membrane and
causes a long-lasting prolongation of the transient increase in
sodium permeability during excitation, presumably by slowing down
the closing of the activation gate of the sodium channel
(Vijverberg & Van den Bercken, 1979; Vijverberg et al., 1983). The
time constant of closing of the activation gate in the
cypermethrin-affected channels is prolonged to more than 100
milliseconds. Apparently, the amplitude of the prolonged sodium
current after cypermethrin is too small to induce repetitive
activity in nerve fibres, but is sufficient to cause the long-
lasting repetitive firing in the lateral-line sense organ.
These results suggest that alpha-cyano pyrethroids primarily
affect the sodium channels in the nerve membrane and cause a long-
lasting prolongation of the transient increase in sodium
permeability of the membrane during excitation.
In the electrophysiological experiments using giant axons of
crayfish, the Type II pyrethroids retain sodium channels in a
modified continuous open state persistently, depolarize the
membrane, and block the action potential without causing repetitive
firing (Lund & Narahashi, 1983).
Diazepam, which facilitates GABA reaction, delayed the onset of
action of deltamethrin and fenvalerate, but not permethrin and
allethrin, in both the mouse and cockroach. Possible mechanisms of
the Type II pyrethroid syndrome include action at the GABA receptor
complex or a closely linked class of neuroreceptor (Gammon et al.,
1982).
The Type II syndrome of intracerebrally administered
pyrethroids closely approximates that of the convulsant picrotoxin
(PTX). Deltamethrin inhibits the binding of [3H]-dihydropicrotoxin
to rat brain synaptic membranes, whereas the non-toxic R epimer of
deltamethrin is inactive. These findings suggest a possible
relation between the Type II pyrethroid action and the GABA
receptor complex. The stereospecific correlation between the
toxicity of Type II pyrethroids and their potency to inhibit the
[35S]-TBPS binding was established using a radioligand, [35S]- t-
butyl-bicyclophosphoro-thionate [35S]-TBPS. Studies with 37
pyrethroids revealed an absolute correlation, without any false
positive or negative, between mouse intracerebral toxicity and in
vitro inhibition: all toxic cyano compounds including
deltamethrin, [1R, cis]-cypermethrin, [1R, trans]-cypermethrin, and
[2S, alphaS]-fenvalerate were inhibitors, but their non-toxic
stereoisomers were not; non-cyano pyrethroids were much less potent
or were inactive (Lawrence & Casida, 1983).
In the [35S]-TBPS and [3H]-Ro 5-4864 (a convulsant
benzodiazepine radioligand) binding assay, the inhibitory potencies
of pyrethroids were closely related to their mammalian toxicities.
The most toxic pyrethroids of Type II were the most potent
inhibitors of [3H]-Ro 5-4864 specific binding to rat brain
membranes. The [3H]-dihydropicrotoxin and [35S]-TBPS binding
studies with pyrethroids strongly indicated that Type II effects of
pyrethroids are mediated, at least in part, through an interaction
with a GABA-regulated chloride ionophore-associated binding site.
Moreover, studies with [3H]-Ro 5-4864 support this hypothesis and,
in addition, indicate that the pyrethroid-binding site may be very
closely related to the convulsant benzodiazepine site of action
(Lawrence et al., 1985).
The Type II pyrethroids (deltamethrin, [1R, cis]-cypermethrin
and [2S,alphaS]-fenvalerate) increased the input resistance of
crayfish claw opener muscle fibres bathed in GABA. In contrast,
two non-insecticidal stereoisomers and Type I pyrethroids
(permethrin, resmethrin, allethrin) were inactive. Therefore,
cyanophenoxybenzyl pyrethroids appear to act on the GABA receptor-
ionophore complex (Gammon & Casida, 1983).
The effects of pyrethroids on end-plate and muscle action
potentials were studied in the pectoralis nerve-muscle preparation
of the clawed frog (Xenopus laevis). Type II pyrethroids
(cypermethrin and deltamethrin) induced trains of repetitive muscle
action potentials without presynaptic repetitive activity.
However, an intermediate group of pyrethroids (1R-permethrin,
cyphenothrin, and fenvalerate) caused both types of effect. Thus,
in muscle or nerve membrane, the pyrethroid induced repetitive
activities due to a prolongation of the sodium current. But no
clear distinction was observed between non-cyano and alpha-cyano
pyrethroids (Ruigt & Van den Bercken, 1986).
Appraisal
In summary, the results strongly suggest that the primary
target site of pyrethroid insecticides in the vertebrate nervous
system is the sodium channel in the nerve membrane. Pyrethroids
without an alpha-cyano group (allethrin, d-phenothrin, permethrin,
and cismethrin) cause a moderate prolongation of the transient
increase in sodium permeability of the nerve membrane during
excitation. This results in relatively short trains of repetitive
nerve impulses in sense organs, sensory (afferent) nerve fibres,
and, in effect, nerve terminals. On the other hand, the alpha-
cyano pyrethroids cause a long-lasting prolongation of the
transient increase in sodium permeability of the nerve membrane
during excitation. This results in long-lasting trains of
repetitive impulses in sense organs and a frequency-dependent
depression of the nerve impulse in nerve fibres. The difference in
effects between permethrin and cypermethrin, which have identical
molecular structures except for the presence of an alpha-cyano
group on the phenoxybenzyl alcohol, indicates that it is this
alpha-cyano group that is responsible for the long-lasting
prolongation of the sodium permeability.
Since the mechanisms responsible for nerve impulse generation
and conduction are basically the same throughout the entire nervous
system, pyrethroids may also induce repetitive activity in various
parts of the brain. The difference in symptoms of poisoning by
alpha-cyano pyrethroids, compared with the classical pyrethroids,
is not necessarily due to an exclusive central site of action. It
may be related to the long-lasting repetitive activity in sense
organs and possibly in other parts of the nervous system, which, in
a more advance state of poisoning, may be accompanied by a
frequency-dependent depression of the nervous impulse.
Pyrethroids also cause pronounced repetitive activity and a
prolongation of the transient increase in sodium permeability of
the nerve membrane in insects and other invertebrates. Available
information indicates that the sodium channel in the nerve membrane
is also the most important target site of pyrethroids in the
invertebrate nervous system (Wouters & Van den Bercken, 1978; WHO,
1979).
Because of the universal character of the processes underlying
nerve excitability, the action of pyrethroids should not be
considered restricted to particular animal species, or to a certain
region of the nervous system. Although it has been established
that sense organs and nerve endings are the most vulnerable to the
action of pyrethroids, the ultimate lesion that causes death will
depend on the animal species, environmental conditions, and on the
chemical structure and physical characteristics of the pyrethroid
molecule (Vijverberg & Van den Bercken, 1982).